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No man is an island entire of itself, 
every man is a piece of the continent, 
a part of the main. 
If a clod be washed away by the sea, 
Europe is the less, 
as well as if a promontory were, 
as well as any manner of thy friends 
or of thine own were. 
Any man's death diminishes me,  
because I am involved in mankind.  
And therefore never send to know for whom the bell tolls,  
it tolls for thee. 
 
John Donne, English scholar and poet 
  
 
  
 
 
 
 
 
 
PREFACE 
The best time to plant a tree was twenty years ago. The second best time is today. 
Anonymous. 
 
On 31st December 2019, the World Health Organization was alerted to several cases of 
pneumonia in Wuhan city, Hubei province, China. The cause of these illnesses turned out to 
be a novel coronavirus, thought to have originated in illegally traded wildlife at a seafood 
market in Wuhan. 
 
I write these words a month later, on the day that the 2019-nCoV outbreak has been declared 
a Public Health Emergency of International Concern by the WHO. Our understanding of the 
outbreak is evolving daily, and there are still many unknowns: Where did the virus emerge 
from? Is there sustained person-to-person spread of the virus in the community? Is the virus 
contagious before symptoms show? How severe is the illness caused by the virus?  
 
The list of actions already taken in China is fascinating, unprecedented, and potentially 
impossible to replicate elsewhere: 
• The city of Wuhan, with a population that exceeds the entire of Sweden, has 
effectively been put into quarantine 
• Two 1000-bed hospitals are being built within ten days in Hubei province 
• A ban has been introduced on the sale of all wildlife at markets throughout China 
• Several major cities have suspended public transport systems and taxis, and the city 
of Tianjin has asked taxi drivers to disinfect vehicles after every passenger 
• The government in Shanghai has stopped businesses from returning to work after the 
Spring Holiday: this applies to all companies apart from utilities, medical firms, 
medical suppliers and supermarkets. 
 
On our highly interconnected planet, one thing is clear: what happens in China matters for 
the world. 
 
 
Lewis Mumford, an American historian and urban planner once wrote that “Every culture 
lives within its dream”. It seems to me that for a long time we have been living within a global 
dream that we can broadly use antibiotics however we like, in humans and animals, without 
needing to worry too much about any negative consequences that may follow. The journey 
described in these pages examines whether this is the case and concludes that to avoid the 
dream becoming a nightmare, we may need to wake up. 
 
Antibiotic resistance has been referred to as an invisible pandemic and a silent tsunami. It is 
critical that we take actions globally to address antibiotic resistance. However, compared with 
the outbreak of a deadly virus, these individual actions are less urgent, less dramatic, and 
perhaps less open to scrutiny. Several novel resistance genes of global significance have been 
identified in China over the past decade. In response to this, and the worldwide situation, 
China has made many impressive commitments to address antibiotic resistance. But much 
more remains to be done, and it is my fervent hope that some clues as to what this could 
involve are contained within the pages you are about to read. 
 
Stockholm, 30th January 2020  
 
 
 
 
 
 
  
 
 
 
 
 
 
ABSTRACT 
 
Background: Tackling the misuse and overuse of antibiotics is critical both for global 
sustainable development and for reducing social inequalities in the world. The World Health 
Organisation Global Action Plan on antimicrobial resistance calls on all Member States to 
develop multi-sectoral National Action Plans and to “monitor and promote optimization of 
antimicrobial use at national and local levels”. There is a particular need to assess how 
antibiotics are being used in resource-limited settings, which tend to have the highest burdens 
of infections and of antibiotic resistance. In such settings antibiotics are commonly overused 
and misused in agriculture too, emphasizing the need for One Health approaches. In 2010, 
China was estimated to be the second largest consumer of antibiotics for human use by total 
volumes, and the largest consumer of antibiotics within food animal production. Information 
on antibiotic use in human healthcare in rural areas is lacking in China, as is knowledge of 
the volumes and patterns of antibiotic use in agriculture, particularly in backyard pig farms 
which remain highly prevalent. 
 
Aim: To assess how antibiotics are being used for humans and on backyard pig farms in a 
rural region in China. 
 
Methods: All studies were conducted in rural areas of Shandong province, located in eastern 
China. Two main methods were used: analyses of prescriptions from healthcare facilities, and 
surveys of doctors', rural residents' and backyard pig farmers' knowledge, attitudes and 
practices concerning antibiotic use and resistance. In Paper I we assessed the rates and types 
of antibiotics prescribed for patients with common cold diagnoses during one month at thirty 
healthcare facilities in three different counties. These healthcare facilities covered three 
different levels in the rural healthcare system: village clinics, township health centres and 
county hospitals. All 188 doctors working at the healthcare facilities were invited to 
participate in a questionnaire on knowledge and attitudes towards antibiotic use. In Paper II 
we prospectively monitored antibiotic prescribing over a 2.5 year period at eight village 
clinics located around a single town in a rural county. We conducted individual prescriber-
level analyses in order to assess the extent of variations in prescribing practices, focussing on 
prescriptions containing diagnoses of likely viral acute upper respiratory tract infections 
(AURI). In Paper III we assessed the knowledge, attitudes and practices towards antibiotic 
use and resistance of 769 rural residents living in the twelve villages that are served by the 
village clinics in Paper II. In Paper IV we assessed the knowledge, attitudes and practices 
towards antibiotic use in pigs of the 271/769 rural residents who had backyard pig farms. We 
also observed the rates and types of antibiotics stored in households for use in humans and 
pigs in Papers III and IV. 
 
Results: Over half of all prescriptions with a common cold diagnosis at healthcare facilities 
in Paper I contained at least one antibiotic, as did almost two-thirds of the prescriptions for 
likely viral AURIs at village clinics in Paper II. The majority of antibiotics prescribed were 
broad-spectrum. Antibiotics were more likely to be prescribed on common cold prescriptions 
from village clinics than on prescriptions from higher level healthcare facilities. There was 
widespread variation in the antibiotic prescribing practices of individual village doctors. 
Significant gaps existed between doctors' knowledge and attitudes, and their actual 
prescribing practices, despite a majority of doctors reporting that they had recently attended 
training on rational antibiotic use.  
 
Rural residents and backyard pig farmers had low levels of knowledge about what antibiotics 
are and when they should be used. Rural residents more frequently thought that antibiotics 
are needed for infectious conditions than for non-infectious conditions, but they did not 
differentiate significantly between infections caused by bacteria, where antibiotics may be 
needed, and those caused by viruses, where they are not. Rural residents commonly reported 
acquiring antibiotics without prescriptions, as well as using leftover antibiotics. Similarly, 
backyard pig farmers reported frequently using antibiotics in healthy pigs when they are not 
needed, and purchasing antibiotics without consulting veterinarians. Backyard pig farmers 
had differences in their knowledge, attitudes and practices towards antibiotic use in humans 
compared with other rural residents, and these appeared to be inter-related with their 
knowledge, attitudes and practices towards antibiotic use in pigs. Household storage of 
antibiotics for human use was common, and similar to levels identified in previous studies in 
Asia; storage of antibiotics on backyard pig farms was also frequent, and many of the stored 
antibiotics are considered to be critically important for human medicine.  
 
Conclusions: The work in this thesis strongly suggests that antibiotics are not being used 
responsibly enough for humans and on backyard pig farms in the study region: doctors, rural 
residents and backyard pig farmers in rural Shandong province are frequently overusing and 
misusing antibiotics. There is a need to investigate which additional drivers are causing 
doctors to prescribe antibiotics unnecessarily, despite knowing that they are not needed. 
Rural residents' and backyard pig farmers' knowledge and attitudes may be contributing to 
overuse and misuse of antibiotics, for example through having expectations to receive 
antibiotics from healthcare professionals in situations for which they are not clinically 
needed. In resource-limited settings, high quality, cross-sectoral assessments of antibiotic use 
at a small number of study sites can provide valuable insights into how responsibly antibiotics 
are being used. 
 
 
Keywords: Community; Consumption; Outpatient; Rational use; Prescriptions; Knowledge, 
attitudes and practices; Antibiotic resistance; Antibiotic stewardship; Global health. 
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The world is full of paradox: we discover the existence of antibiotics, a remarkable class of drugs 
that adds several years to the average human’s lifespan and radically alters our expectations of 
normal life. Then, over the course of 70 years we fail to make the value of these drugs accessible 
to all. At the same time, we knowingly overuse these drugs in both humans and animals, 
accelerating the rate at which their value is eroded, while failing to invest in ways to maintain 
and to renew this value. 
 
This raises a crucial question that we must ask ourselves: are we using antibiotics responsibly? 
 
Dyar OJ et al., Future Microbiology, 2016 
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1 INTRODUCTION 
 
There is an old saying: as a medicine, it is somewhat toxic. How can medicines cure diseases if 
there are no poisonous components? There will surely be side effects. 
Focus group respondent, rural Shandong province 
 
1.1 THE IMPORTANCE OF USING ANTIBIOTICS RESPONSIBLY 
1.1.1 It matters how we use antibiotics 
Antibiotics can be life-saving medicines. Since their introduction into clinical practice, they 
have transformed how we treat bacterial infections, and our ability to rely on their 
effectiveness underpins many aspects of modern medicine [1]. Antibiotics are also essential 
for animal welfare and for food production [2]. 
 
Antibiotics may be the epitome of a wonder drug [3], but it still matters how we choose to 
use them [4,5]. As with other medicines, they can be overused (i.e. used when they are not 
needed), misused (i.e. an inappropriate antibiotic choice or dose is selected) and underused 
(i.e. not used when they are needed). The overuse and misuse of antibiotics has direct 
consequences for individual patients, including elevated risks of adverse events such as 
organ-specific toxicities and hypersensitivity reactions [6,7], impacts on the normal 
microbiome [8,9], and economic costs such as out-of-pocket expenditures [10,11]. The 
consequences of underusing antibiotics depend on the specific infection that goes untreated. 
 
Critically, antibiotic use also accelerates the naturally occurring processes of development 
and spread of resistant bacteria [12,13]. In individual patients antibiotic use can lead to the 
development of resistance during treatment [14], as well as an increased probability of 
colonisation with resistant bacteria after treatment [15–17]. Overusing and misusing 
antibiotics further increases the likelihood of these processes happening [5]. For example, 
healthy livestock are sometimes fed low doses of antibiotics over extended periods of time as 
growth promoters, separate from using antibiotics to treat and prevent infections; these 
livestock tend to have higher subsequent isolation rates of resistant bacteria [18]. 
 
Rising prevalence rates of resistant bacteria in turn have important consequences. For 
individuals, infections caused by resistant bacteria are associated with longer illness durations 
and higher mortality rates, as well as elevated costs from needing second- or third-line 
treatments and longer-hospital stays [19,20]. For societies, rising antibiotic resistance rates 
lead to increased treatment costs and longer recovery times during which individuals are 
unable to work [21,22]. Modelling suggests that resistant bacteria already account for at least 
33,000 additional human deaths in Europe each year [23]. If trends continue, global gross 
domestic product (GDP) is predicted to be 2-3.5% lower by 2050 than it would otherwise be 
[24], similar to estimates for the impact of climate change over the same time period [25,26]. 
 
The growing scientific and political understanding of the threats posed by antibiotic 
resistance has led to several high-level actions and commitments. These include the World 
Health Organization’s (WHO) Global Action Plan on antimicrobial resistance, which was 
adopted in 2015 [4]. Broadly, the challenges of antibiotic resistance can be tackled by 
developing antibiotics with new mechanisms of action (innovation), by improving access to 
existing effective antibiotics (access) and by preserving the effectiveness of existing antibiotics 
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(conservation), which includes reducing the need to use antibiotics through improvements 
in public health, vaccination coverage, and infection prevention and control [27,28]. 
Currently, innovation efforts are being impeded by a range of economic, regulatory and 
societal challenges [29]. A recent analysis found that most of the sixty products in clinical 
development bring little benefit over existing treatments, and only two are active against the 
critical multidrug resistant gram-negative bacteria [30]. This further highlights the urgent 
need to invest in conservation efforts, which includes minimising the misuse and overuse of 
antibiotics. A recent United Nations Children’s Fund (UNICEF) report termed antimicrobial 
resistance as one of the biggest generational threats to childhood health and survival, and 
prioritised three responses which are all related to conservation: reducing infection rates, 
promoting access to and optimal use of antibiotics, and increasing awareness and 
understanding of antimicrobial resistance [31]. 
 
In summary, the misuse and overuse of antibiotics has important negative consequences for 
patients, the healthcare system and society, including unnecessarily exacerbating the burden 
of antibiotic resistance. 
 
1.1.2 Antibiotic resistance and social inequalities are interlinked 
The burden of antibiotic resistance is not spread equally [32]. It is increasingly clear that 
social inequalities can drive antibiotic resistance, and that antibiotic resistance can in turn 
exacerbate social inequalities [33,34]. This occurs on a global scale, as well as within 
individual countries. Diderichsen et al. developed a framework for illustrating the central 
mechanisms related to social inequalities in health (Figure 1) [35]. This framework can 
highlight the paths through which social inequalities can occur for infections with resistant 
bacteria and also for antibiotic overuse and misuse, as described below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Central mechanisms (I-V) and policy entry points (A-D) related to social 
inequalities in health (adapted from [35]) 
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Differential exposures (arrow II): the social position of a person within a society affects the 
risk factors that they are exposed to through their work, economic circumstances, physical 
environment and health behaviours [35]. Several of these factors are relevant to both 
infections with resistant bacteria and inappropriate or unnecessary antibiotic use. For example, 
household crowding has been associated with an elevated risk of community-associated 
methicillin-resistant Staphylococcus aureus (MRSA) infections in the US, and with higher 
antibiotic use rates in New Zealand [36,37]. Similarly, studies have shown associations 
between working with livestock and human carriage of resistant bacteria [38,39]. 
 
Differential vulnerabilities (arrow III): due to interaction effects, the strength of the effect 
of an individual risk factor is affected by the presence of other risk factors for the same illness 
[35,40]. Particularly in poor resource settings, several risk factors for infections in general can 
cluster among individuals in lower socioeconomic groups, for example poor nutrition, and 
poor access to clean water and sanitation facilities [33,34,41]. Risk factors for infections in 
general will also tend to act as risk factors for infections with resistant bacteria and for 
inappropriate or unnecessary antibiotic use: as infection rates rise, so too does the risk in 
absolute terms for suffering from an infection caused by resistant bacteria (since a proportion 
of all infections will be caused by resistant bacteria), as does the risk for antibiotic overuse or 
misuse (since a proportion of all antibiotic use will prove to be unnecessary or inappropriate). 
 
Differential disease consequences (arrow IV): social position can impact access to 
treatment and rehabilitation, and thus affects survival, functional ability, quality of life and 
employment [35]. As antibiotic resistance rates rise, access to antibiotics that work is an 
important challenge in poor resource settings. It has been estimated that nearly 450,000 
childhood pneumonia deaths each year are due to an inability to access effective therapy that 
already exists [42]. Second- and third-line antibiotics tend to be more expensive, so even 
when effective antibiotic therapy is available, individuals may struggle to afford them [34]. 
 
Tackling antibiotic resistance, including the drivers of overuse and misuse, is critical both for 
global sustainable development and for reducing social inequalities in the world [41,43]. 
 
1.1.3 Defining responsible antibiotic use 
Over the past few years there have been several efforts to define what responsible antibiotic 
use is, both in human medicine and veterinary medicine [44–48]. These efforts include a large 
expert consensus procedure which ultimately reached agreement on 22 separate elements 
[49]. I summarised some of these discussions together with co-authors in a perspective piece 
[50], and further highlighted two dimensions in the Oxford English Dictionary definition of 
“responsible” [51] that we felt were particularly relevant. 
 
First, a responsible practice is one that is carried out in a morally principled way. This is where 
the majority of discussions on antibiotic use have centred, particularly when defining 
"optimal use", "rational use" and "appropriate use" in the context of antimicrobial stewardship 
efforts [47]. Second, to be responsible is to be capable of fulfilling an obligation or duty. We 
suggested that we have a global obligation to ensure sustainable access to antibiotics for all 
those who need them, but that this dimension has been under-emphasised in discussions so 
far [50]. This perspective encourages viewing antibiotics as resources that are potentially non-
renewable, and there is indeed much that can be learnt from examining how societies manage 
other non-renewable resources. Being responsible involves looking beyond individual 
antibiotic uses to the broader environments in which they occur: for example, what 
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regulations and educational efforts are we putting in place as a society to promote using 
antibiotics in sustainable ways? Using antibiotics responsibly is thus about individual 
antibiotic practices and also how we can shape contexts to be conducive to responsible 
antibiotic use. Table 1 shows examples of where we may fail in this responsibility. 
 
Table 1. Responsibility in the context of using antibiotics 
Individual practices that are not responsible Not being responsible – the broader context 
Using antibiotics for conditions where there is 
no evidence of efficacy (e.g. common colds) 
Failing to educate the public about antibiotics 
in contexts where they have easy access to 
antibiotics (e.g. over-the-counter) 
Prescribing broad-spectrum antibiotics when 
narrow-spectrum antibiotics are as effective 
Allowing widespread variations in the quality 
of antibiotic use between prescribers 
 
1.1.4 Why do we not always use antibiotics responsibly? 
Ideally, antibiotics would only be used when they provide a clinical benefit, and when this 
benefit is considered to not outweigh the need to conserve antibiotic effectiveness for future 
patients – i.e. antibiotics would not be overused. Furthermore, when an antibiotic is used, an 
optimal choice, dose and route would be selected – i.e. antibiotics would not be misused. 
These principles can be applied to antibiotic use in both humans and animals [46,47,52–54]. 
There are, however, a wide range of broader determinants that shape how responsibly 
antibiotics are used today, in addition to clinical need [1,55,56]. 
 
At the individual-level, limitations in prescriber and patient knowledge and attitudes are 
common and can lead to inappropriate and unnecessary antibiotic use [57–59]; even when 
appropriate knowledge is held, entrenched behaviours and habits can take precedence and 
result in suboptimal practices [60]. Several additional factors may nudge prescribers, patients 
and societies into overusing or misusing antibiotics in humans and animals. For example, 
reimbursement systems may leave hospitals and veterinarians reliant on antibiotic sales to 
generate income to cover their operating costs [61,62]; pharmacies and drugstores may 
dispense antibiotics to patients as a way to make additional profits, whilst also selling other 
over-the-counter symptom-relieving medications to patients [63]; a lack of restrictions on 
pharmaceutical industry advertising may promote unnecessary antibiotic use [21,64]; and 
more broadly, a culture may encourage healthcare-seeking and use of antibiotics for non-life-
threatening illnesses so that its population can experience symptoms for shorter periods of 
time, return to productive work more quickly, or simply feel reassured [65]. 
 
These individual-level and system-level determinants of antibiotic use can vary widely 
between settings [21]. A context-specific understanding of the determinants of antibiotic use 
is thus needed to support interpretations of data on how antibiotics are being used, as well as 
to adapt interventions to improve antibiotic use. 
 
1.2 ANTIBIOTIC USE NEEDS TO BE ASSESSED 
Since antibiotics may not always be used responsibly, there is a need to assess how antibiotics 
are actually being used in practice. There is evidence from a wide range of countries that not 
all antibiotic use today is optimal; indeed, studies commonly suggest that up to a half of all 
antibiotic prescriptions in human medicine are either unnecessary or inappropriate, both in 
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inpatient and outpatient settings [66–69], and that patient adherence with prescribed 
antibiotics is also suboptimal [58]. It is harder to estimate the proportion of antibiotic overuse 
and misuse in animals, but there are suggestions that it is of at least the same order of 
magnitude as in humans [70]. 
 
The WHO Global Action Plan on antimicrobial resistance calls on all Member States to 
develop multi-sectoral National Action Plans and to “monitor and promote optimization of 
antimicrobial use at national and local levels” [4]. Assessing how antibiotics are being used is 
needed for several reasons, including: 
• To understand when, how and why antibiotics are overused, misused and underused 
• To provide feedback to individual prescribers, dispensers and consumers of 
antibiotics, in order to improve practices 
• To assess the impact of interventions that aim to improve antibiotic prescribing, 
dispensing and use 
• To better understand the relationship between intensity of antibiotic use and the 
emergence and spread of antibiotic resistance within countries and individuals 
 
1.2.1 One Health approaches are needed 
One Health is the collaborative effort of multiple disciplines – working locally, nationally, 
and globally – to attain optimal health for people, animals and the environment [71]. The 
WHO, the World Organization for Animal Health (OIE) and the Food and Agriculture 
Organization of the United Nations (FAO) all acknowledge the importance of One Health 
approaches in coordinating global activities to address health risks, as demonstrated by the 
tripartite concept note in 2010 [72]. Antibiotic resistance has been described as the 
quintessential One Health issue [73] with bacteria such as Escherichia coli capable of 
spreading between humans, animals and the environment, along with antibiotic resistance 
genes and antibiotic residues. This One Health perspective is particularly relevant in many 
resource-limited rural community settings in which humans and animals live closely, often 
with small-scale “backyard farms” on the same site as a house (Figure 2) [39]. 
 
Figure 2. Potential spread of E. coli on backyard farms (adapted from [74]) 
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The WHO Global Action Plan on antimicrobial resistance, in which OIE and FAO have 
distinct roles, recognizes that antibiotic use needs to be assessed in both human and animal 
sectors, moving towards a One Health perspective [4,75,76]. To facilitate this, the OIE has 
developed a voluntary data collection system on the use of antimicrobial agents in animals, 
to which any country can contribute [77]. These approaches are necessary to understand the 
total antibiotic use occuring within a region, and consequently the overall ecological pressure 
placed on bacteria [78,79]. Furthermore, determinants for misuse and overuse may cross 
sectors within settings; for example, ease of access to antibiotics without prescriptions in 
pharmacies for both human and animal use. Similarly, it is possible that interventions can be 
developed that can simultaneously improve antibiotic use in humans and animals [80,81]. 
 
Data are also needed from environmental sources to complete the One Health perspective 
[82]. These include information on how pharmaceutical companies dispose of potentially 
active by-products from the antibiotic manufacturing process [83], and on the antibiotic 
residue contents of hospital wastewater effluents [84]. These assessments lie outside of the 
scope of the present thesis which focusses on antibiotic use in humans and animals, and so 
are not considered in further detail. 
 
1.2.2 Methods and data sources for assessing antibiotic use 
Figure 3 shows a simplified map of the main pathways that antibiotics take through a 
healthcare system, from manufacturing through to consumption. Similar pathways exist for 
antibiotic use in animals, although a greater diversity of actors may be involved. 
Figure 3. Simplified flows of antibiotics through a healthcare system 
 
Typically, a manufacturer sells antibiotics to a wholesaler, which will then sell the antibiotics 
to healthcare facilities (e.g. hospitals, outpatient clinics) and to pharmacies. In some settings 
a central procurement agency may act as an intermediary between multiple wholesalers and 
multiple healthcare facilities and pharmacies [85]. At healthcare facilities antibiotics are then 
prescribed by doctors and other qualified personnel to patients, and they can either be 
dispensed in the facility (normal for inpatients) or at a separate outpatient pharmacy. In some 
settings antibiotics can also be acquired by consumers directly from pharmacies without a 
prescription (referred to as over-the-counter use) [86]. The final stage is the consumption of 
an antibiotic by the consumer. Patients may have leftover antibiotics, for example if they 
choose not to complete the full course prescribed; they may choose to store these for a later 
illness and use them independently of healthcare providers (an example of self-treatment). 
 
Assessments of antibiotic use can be made at different points on these pathways. The 
common strengths and limitations of different methods and data sources for assessing 
antibiotic use are presented in Table 1, compiled from studies conducted in high-, middle- 
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and low-income settings. In general, data from higher levels in the healthcare system (e.g. 
wholesaler sales to healthcare facilities and pharmacies) provide information on quantity that 
allows comparisons to be made between facilities, regions and countries in terms of intensity 
of antibiotic use [87,88]. These data are important for policy makers [89,90], and can permit 
observation of the potential influences that changes in policy have at a whole system level; 
however, in isolation these data may not provide much insight into the quality, or 
appropriateness, of individual antibiotic uses. Their distance from the end consumer also 
means they may provide less accurate estimates of actual consumption by patients [89]. 
Assessing the quality of antibiotic use is facilitated by capturing clinically relevant 
information [91–93], which is available at lower levels in the healthcare system (e.g. from 
healthcare facilities, pharmacies, consumers) [94,95]. This data on the appropriateness of 
antibiotic use is important for identifying targets to improve antibiotic use [96], and can be 
used as a source of feedback to healthcare facilities and prescribers [97,98]. However, data at 
the lower levels are often resource-intensive to collect and they can lack generalisability 
beyond the specific setting in which they are collected [89]. 
 
In general, there have been far fewer efforts to assess antibiotic use in animals, compared with 
in humans [79,99]. Many of the methods used for assessing antibiotic use in humans can be 
applied to assessing how antibiotics are being used in animals, and the strengths and 
limitations will be broadly similar. 
 
1.2.3 Assessing antibiotic use within a region 
Adapting assessment methods to the context in which they are used strengthens their power 
to provide accurate, reliable and actionable information on how antibiotics are being used. 
No single assessment method is capable, however, of comprehensively describing how 
antibiotics are being used across the whole healthcare system in a region. The different 
assessment methods provide information that complement one another, and a holistic 
understanding of how antibiotics are being used can only be reached by combining the data 
from multiple assessment methods. Furthermore, each assessment method provides 
information on different parts of the healthcare system as a whole [1], which can be essential 
for providing the context necessary to interpret results: for example, procurement data can 
shed light on financial incentives for facilities to overuse antibiotics, and prescription data 
can indicate how frequently alternatives to antibiotic therapy are being used. 
 
1.2.4 Challenges in resource-limited settings 
There is a particular need to assess how antibiotics are being used in resource-limited settings 
[100,101]. Globally, these settings have the highest burdens of infections and of antibiotic 
resistance [33,34,102]. Antibiotics have often been used to plug gaps in public health, and 
there is frequently evidence of concurrent antibiotic overuse, misuse and underuse [103,104]. 
In such settings antibiotics are commonly overused and misused in agriculture too, 
emphasizing the need for One Health approaches to understand and tackle problems [39,76]. 
 
In most countries, the vast majority of human antibiotic use occurs for outpatients in 
community settings, but these are often the hardest settings in which to obtain data. Beyond 
the inherent methodological limitations mentioned in Table 1, there are additional challenges 
when assessing antibiotic use in resource-limited settings [100]. First, systems for capturing 
data may be less mature and less comprehensive (e.g. paper-based prescriptions and 
dispensing records; surveillance limited to public sector facilities); second, fewer resources 
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may be available (e.g. trained personnel; technology; funding); third, a wider range of sources 
for antibiotics may exist (e.g. over-the-counter sales; cross-border sales; donations; self-
medication); fourth, different patterns of disease prevalence and antibiotic susceptibility may 
exist both between and within countries.     
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Table 2. Strengths and limitations of data sources used for assessing antibiotic use in humans 
 
Data sources Strengths Common limitations and missing data 
Wholesaler data and 
aggregated sales data 
• May capture over-the-counter sales [105,106] 
• Allows for standardised data collection across a range 
of facilities [107] 
• Can compare trends in sales of antibiotics with sales of 
other medicines (and potentially assess changes in 
response to policies) [108] 
• Potentially a large number of independent wholesalers 
• May be difficult to define population denominator 
• May be limited to public or private sector only [90] 
• Cannot account for spoiled or expired stock that is not 
consumed [109] 
• Lacks patient-specific data and clinical usage data 
Procurement records 
• May be possible to disaggregate data (e.g. to healthcare 
facility type and location) [85,110] 
• Potentially only one data source needed if centralised 
procurement is used [110] 
• Can be used to assess the impact of new policies [111] 
• Can compare trends in procurement of antibiotics with 
other medicines [111] 
• May only provide data for the public sector [85,111] 
• Rare medicines may not be covered by main 
procurement mechanisms [110] 
• May miss over-the-counter sales [110] 
• Cannot account for spoiled or expired stock that is not 
consumed [109] 
• Lacks patient-specific data and clinical usage data 
Insurance and 
reimbursement records 
• May be the only information system available that links 
clinical diagnosis with antibiotic prescriptions [94] 
• May be simple to collect data if only a small number of 
insurance providers exist [87,112] 
• Can help in benchmarking and in assessing variation 
between healthcare facilities [112] 
• Insurance data may provide denominators for numbers 
of people covered [113] 
• Some antibiotics may be excluded due to not being 
reimbursed (e.g. due to antibiotic type, or patient 
demographic) [105,106] 
• May only include limited clinical data [112] 
• Insurance schemes may differ in patient membership 
(e.g. socio-demographics, co-morbidities) [113] 
• Misses over-the-counter sales [105,106] 
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Data sources Strengths Common limitations and missing data 
Prescribing records 
(inpatient and 
outpatient) 
• Defined patient population (particularly for inpatient 
data) [32] 
• Prescribed antibiotics are likely to be consumed 
(particularly for inpatient data) [32,114] 
• May capture prescription and patient characteristics, so 
can be possible to assess influencing factors (diagnosis, 
socio-demographics) [32,69,115,116] 
• Allows analysis of other medicines prescribed 
concurrently with antibiotics [117] 
• Potential to capture behaviour at individual prescriber 
level or facility level, and provide feedback [32,116] 
• May allow easy access to population subgroups (e.g. 
pediatric populations) [118] 
• Not all outpatient prescriptions will be dispensed or 
consumed 
• Misses over-the-counter sales [115,119] 
• May not be possible to validate diagnoses for data from 
only prescriptions rather than medical records [69,116]  
• Outpatient encounters may not always lead to a 
prescription, making comparisons between settings 
difficult 
• Datasets for outpatient care may not be comprehensive 
(e.g. missing long-term care facilities, emergency 
department visits) [69] 
Pharmacy dispensing 
records (outpatient) 
• Can capture over-the-counter sales [63,86,120] 
• May capture financial incentives for sales [86] 
• May allow easy access to population subgroups (e.g. 
pediatric populations) [118] 
• May allow individual patient exposure to antibiotics to 
be calculated [121] 
• May be resource intensive due to large number of 
facilities [63] 
• Private companies may be unwilling to share data [63] 
• Small drugstores may have incomplete records [63] 
• Data may only be available at pack level (i.e. not on 
prescribed duration of courses) [115,118] 
End consumers 
• May accurately reflect end consumption of antibiotics 
for individual patients [63,122] 
• Provides information on storage of leftovers, self-
medication or sharing with others [95,123,124] 
• May capture over-the-counter acquisition [63,124,125] 
• Can help identify patterns of healthcare seeking 
behaviours [63,125,126] 
• Can be highly resource intensive [61,127] 
• May include selection biases and recall biases [124,127] 
• Clinical information may be lacking (i.e. clinical signs, 
microbiological investigations) [122] 
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1.3 ANTIBIOTIC USE IN HUMANS AND ANIMALS IN CHINA 
1.3.1 The People’s Republic of China: an introduction 
China is an upper-middle income country covering approximately 9.6 million square 
kilometres, with landscapes ranging from deserts in the arid north to subtropical forests in 
the wetter south and including the third longest river in the world. China has been a one-
party socialist state since the end of the Chinese Civil War in 1949 and is divided into 22 
provinces, five autonomous regions, and four municipalities (collectively referred to as 
"mainland China"), as well as the special administrative regions of Hong Kong and Macau. 
 
China is the most populous country in the world and had a population of 1.38 billion in 2018 
[128]. The majority of the population (57%) now lives in urban areas, a rapid increase from 
25% thirty years ago, and there are over 100 cities in China with more than a million 
inhabitants. Life expectancy at birth is 73.6 years for males and 79.4 for females, although 
there are regional variations [128]. China is one of the world’s fastest growing economies, 
and it has been the largest economy in the world since 2014 by purchasing power parity [129]. 
Economic inequality has increased considerably since the 1990s, reaching a Gini coefficient 
of approximately 0.50 in 2013 [128,130]; a Gini coefficient of 0 signifies that everyone has the 
same income, and 1 implies that a single person or household has all the income. For 
comparison, Sweden had a Gini coefficient of 0.29 in 2015 [128]. The extreme level of income 
inequality is thought to be driven by structural factors including long-standing government 
development policies that have favoured urban residents over rural residents, and residents 
from coastal, more developed regions, over residents from less developed, inland regions 
[130]. The average annual per capita income of urban households in China in 2018 was 
almost 40,000 RMB (11,000 Intl$), compared with just under 15,000 RMB (4,200 Intl$) for 
rural households [128,131]. Historically, there have also been important differences in access 
to education between rural and urban residents. Several government policies have been 
introduced in recent years to address growing inequalities, spanning the labour market, 
healthcare and education [132]. 
 
1.3.2 Antibiotic use and resistance in China 
In 2010, China was estimated to be the second largest consumer of antibiotics for human use 
by total volumes, and the largest consumer of antibiotics within food animal production 
[70,107]. As in many countries, around half of all antibiotics used in China are thought to be 
consumed by livestock [133,134], both as growth promoters and to prevent and treat disease. 
The volume of antibiotics used in agriculture is predicted to increase by two-thirds by 2030 
due to human population growth and the rising demand for meat [70]. 
 
There are national surveillance systems for monitoring antibiotic use (Mohcas) and antibiotic 
resistance (Mohnarin), but both systems mainly include data from large urban hospitals, and 
so are not fully representative of China as a whole [62]. Studies that have assessed per capita 
antibiotic consumption levels in humans have generally reported these to be similar to 
European levels, and lower than levels in high-income Asian countries [107,110]. Smaller 
scale studies, however, suggest that there is frequent over-prescribing of antibiotics, 
combined with high levels of self-treatment [95,119,125]. One study reported that over 60% 
of parents living in a rural region had given their children antibiotics in the previous year 
without consulting a doctor; in the same study, children were reported to also have been 
prescribed a median of two courses of antibiotics by doctors in the preceding six months [95]. 
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In general, data on antibiotic use in rural areas is lacking. A systematic review published in 
2013 only included two studies from rural healthcare facilities [135]. There is also currently 
little data on the volumes and patterns of antibiotic use in agriculture, in particular in 
household backyard farms which are highly prevalent in rural China [136]. Many drivers 
promote the overuse of antibiotics in humans and animals, including financial incentives for 
facilities and individual prescribers; a lack of microbiology facilities in rural healthcare 
facilities; pharmaceutical industry advertising to consumers; low levels of public knowledge 
about antibiotic use and resistance; and low numbers of trained veterinarians for backyard 
farms [136–138]. 
 
Clinical studies at individual hospitals and national surveillance data collected by the 
Ministry of Health have identified high rates of resistance in a variety of bacterial pathogens, 
in particular Enterobacteriaceae and Acinetobacter spp. [139,140]. Highly resistant bacteria 
have been identified in a range of agricultural settings too, as have individual antibiotic 
resistance genes such as mcr-1 which confers resistance to colistin, a last-resort antibiotic in 
human medicine [141,142]. Several factors have contributed to the spread of resistant 
bacteria in China, including high population densities; economic migration; frequent human 
and animal interactions (particularly in rural areas); and inadequate wastewater treatment 
facilities [61,139]. 
 
1.3.3 The healthcare system in rural China 
1.3.3.1 Structure and resources  
The main health authority at the state level is the National Health Commission of the People’s 
Republic of China (NHC) [143]. The central government remains the leading force in law-
making and decision-making, despite several waves of reform attempting to streamline 
administration and promote decentralization. 
 
China has had a three-tier healthcare delivery system in urban and rural areas since the 1960s 
[143]. In rural areas this consists of village clinics, township health centres, and county 
hospitals. In 2018 there were approximately one million medical institutions in China, with 
8.7 hospital beds per 1,000 people in urban areas and 4.6 in rural areas, and with 4.0 licensed 
doctors per 1,000 people in urban areas and 1.8 in rural areas [131]. In comparison, in Sweden 
there were 2.4 hospital beds and 4.3 licensed doctors per 1,000 people in 2016 [144]. 
 
Health resources tend to be concentrated in hospitals in both urban and rural areas. Primary 
care facilities (village clinics and township health centres) provide primary medical services 
and basic public health services to rural residents. Hospitals are responsible for most 
specialist outpatient and inpatient services, but will additionally offer primary medical 
services [143]. The majority of hospitals are private (64% in 2018), whereas most village 
clinics are public (67% in 2018) [131].  
1.3.3.2 Financing, including reimbursements of medicines 
In 2018, China’s total health expenditure accounted for 6.6% of its GDP, with 28% covered 
by the government’s budget, 44% by social insurance and 29% by individual out-of-pocket 
payments [131]. Almost all rural residents are covered by one of two social insurance 
schemes: the urban employee-based health insurance scheme (mandatory for workers in 
urban areas, and financed by premiums from employers and employees) and the new rural 
cooperative medical scheme (financed by individual premiums and the government). All 
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medicines on the national essential medicines list [145] are included in the pharmaceutical 
reimbursement catalogues for the basic medical insurance schemes, and these are reimbursed 
at higher rates than other medicines. Further local adaptation of the essential medicines list 
is permitted. A policy of zero mark-up on sales of essential medicines has been in place since 
2012 at village clinics, and earlier at other public primary care facilities [143,146]. This means 
that village doctors are unable to profit from sales of essential medicines; instead, village 
doctors are compensated with supplemental subsidies [85,143]. 
1.3.3.3 Medical education and types of doctor 
China has, over time, established a comprehensive medical education system. This consists 
of undergraduate education, postgraduate education and continuing professional 
development. It is organized by the Ministry of Education, but local health authorities 
manage the training of medical specialists within each jurisdiction [143]. In rural areas, 
county hospitals and township health centres are staffed by a mixture of licensed physicians 
who typically have a five-year bachelor’s degree or above, and who majored in medicine at 
college or university. In addition, there are many assistant licensed physicians who are 
graduates of colleges, universities or junior college, and who typically hold a three-year 
medical vocational degree. Village clinics are staffed by village doctors who hold a “village 
doctor” certificate and who have had varying durations of basic training. Many village 
doctors were first trained as part of the “barefoot doctor” programme in the 1960s and 1970s 
which led to the remarkable achievement of every village in China having at least one village 
doctor and one village clinic [143]. However, their training was short, commonly less than 
six months long. Continued professional development exists today for doctors at all health 
facilities, but varies in its availability and quality [143]. Village doctors do not have exactly 
the same prescribing rights as doctors working at township health centres and county 
hospitals, but all doctors are permitted to prescribe a wide range of narrow- and broad-
spectrum antibiotics [147]. 
1.3.3.4 Outpatient pathways 
Patients are able to freely choose which medical facilities they seek help at. Importantly, there 
is no fully developed gatekeeping and referral system, so hospitals must also offer primary 
healthcare services [143]. Higher level facilities are perceived in general to be of higher 
quality, but patients are required to pay higher out-of-pocket costs for attending these. For 
outpatient care, approximately half of all rural residents will first seek help at a village clinic, 
a quarter at township health centres, and the remainder at county or higher-level hospitals 
[143]. For residents living in villages, the village clinic will usually be their first choice if they 
believe their illness is not severe.  
1.3.3.5 Policies and regulations on antibiotic use in human medicine 
National policies and guidelines have been issued over the past decade to address irrational 
antibiotic use in human healthcare, and these have led to some improvements [62,114]. These 
efforts include guidelines for antimicrobial use which were published in 2004, the creation of 
an antimicrobial use and monitoring network in 2005, and guidelines for prescription audits 
which were published in 2010 [114]. Over-the-counter sales of antibiotics have been illegal 
since 2004 [61]. The NHC launched a three-year national campaign in 2011 to further 
improve the use of antibiotics. This campaign focussed on secondary and tertiary hospitals, 
and involved implementing antibiotic stewardship programmes, classifying antibiotics into 
three categories depending on the rights needed to prescribe them (non-restricted; restricted; 
specialist only), and introducing penalties for facilities that failed to reach specific targets (e.g. 
the proportions of outpatient prescriptions and inpatient medical records with prescriptions 
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of antibiotics should be <20% and <60%, respectively). The Chinese National Action Plan on 
Antimicrobial Resistance was published in 2016. This included targets for the developing new 
drugs, restrictions on over-the-counter access to antibiotics, improvements in surveillance, 
and improvements in antibiotic use in both human and animal sectors [148]. Overall, the 
implementation and effectiveness of policies on improving antibiotic use has been limited in 
rural settings due to a relative lack of supervision and supporting infrastructure, and fewer 
training opportunities [62,66,138]. 
 
1.3.4 Agriculture in rural China: focusing on pigs 
With the exception of milk, China is the largest producer of all major agricultural products, 
accounting for 28% of global meat production in 2013 [134]. In 2016, pork accounted for 
62% of all meat produced in China, followed by poultry meat (22%), beef (8%) and sheep 
meat (5%) [134]. 
 
Pig production occurs at a mixture of large-scale commercial farms, medium-scale 
specialised farms, and small-scale backyard pig farms [149]. Backyard farms are still highly 
prevalent in rural areas, despite recent waves of consolidation within the pork industry. 
Farms with fewer than 50 pigs (a typical size for backyard farms) accounted for 95% of all pig 
farms and 35% of all slaughtered pigs in China in 2011 [150,151]. Backyard pig farms are 
usually managed by a single household, as in many low- and middle-income countries [39]. 
1.3.4.1 Veterinary services in rural China 
A veterinary and para-veterinary workforce supports farmers in rural areas. This includes 
government veterinarians who are responsible for disease prevention and control, and 
private veterinarians, who are sought by farmers when their animals are ill. Para-
veterinarians are permitted to diagnose diseases, but only licensed veterinarians can prescribe 
antibiotics. Antibiotics should be prescribed from an essential medicines list that contains 
broad- and narrow-spectrum agents [152]. As with human pharmacies, animal pharmacies 
must be licensed and are expected to be inspected annually [153]. Farmers pay for medicines 
and the services of veterinarians, and they are required to maintain records of all drugs that 
they administer to their animals [153]. 
1.3.4.2 Policies and regulations on antibiotic use in agriculture 
The earliest regulations on uses of antibiotics in agriculture focussed on counterfeit drugs 
and the potential risks of drug residues in meat products [134]. More recent regulations have 
addressed antibiotic resistance, such as the 2014 “Catalogue of veterinary prescription drugs” 
[152], in which 11 classes of antimicrobials that have high rates of resistance and are 
important in human healthcare were classified as prescription-only medicines. Some 
antibiotic agents have been completely banned for use in agriculture [154]. In 2015, a Five-
Year National Action Plan of Comprehensive Management for Veterinary Medicines was 
launched [134]. This included targets such as improving the monitoring of antibiotic 
consumption, halving the numbers of antimicrobial prescriptions in agriculture, and 
educating veterinarians and farmers about responsible antibiotic use.  
 
1.3.5 Collaborations between Sweden and China on antibiotic resistance 
Sweden has long promoted antibiotic resistance on the international political agenda and has 
provided substantial funding for international research projects to address antibiotic 
resistance. These efforts recognise that antibiotic resistance is a problem that cannot be 
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managed within a single country, and that some of the successes in tackling antibiotic 
resistance in Sweden may be relevant for other settings. 
 
In 2006, a Memorandum of Understanding was formed between the Chinese and Swedish 
governments on several areas within the health sector. In 2010, the Chinese and Swedish 
health ministers signed a Plan of Action emphasising cooperation on antibiotic resistance. In 
2012, the Ministry of Agriculture of China and the Ministry for Rural Affairs in Sweden 
signed a Memorandum of Understanding on agriculture cooperation, which again 
emphasised cooperation on antibiotic resistance [155]. Along with these actions, Chinese and 
Swedish researchers have worked together on several research projects to investigate 
antibiotic use and resistance in China [80,114,156]. 
 
The studies in this thesis all take place in the context of these collaborative efforts, supported 
by funding from the National Natural Science Foundation of China, the Swedish 
International Development Cooperation Agency, and the Swedish Research Council. 
Microbiological studies within the same research programmes have identified very high levels 
of resistant bacteria, in particular ESBL- and carbapenemase-producing Enterobacteriaceae, 
among healthy humans [156], healthy animals [157,158] and environmental sources 
[159,160] in rural Shandong province. The papers in this thesis complement these 
investigations by providing insights into the patterns of antibiotic use for humans and on 
backyard pig farms in the same study sites, as well as their determinants.
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2 AIM 
 
The overall aim was to assess how antibiotics are being used for humans and on backyard pig 
farms in a rural region in China. This included individual antibiotic use practices, as well as 
the broader knowledge, attitudes and practices that shape how antibiotics are used. 
 
2.1 RESEARCH QUESTIONS 
1. Are doctors prescribing antibiotics responsibly (Papers I and II), and are rural residents 
(Paper III) and backyard pig farmers (Paper IV) using antibiotics responsibly? 
 
2. Is there significant variation in the antibiotic prescribing practices of doctors? (Papers I 
and II) 
 
3. What are the knowledge and attitudes of doctors (Paper I), rural residents (Paper III) and 
backyard pig farmers (Paper IV) concerning antibiotic use and resistance? 
 
4. Are there differences between backyard pig farmers and other rural residents in terms of 
knowledge, attitudes and practices concerning antibiotic use? (Paper III) 
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3 METHODS 
3.1 STUDY SETTING: SHANDONG PROVINCE, CHINA 
All studies were conducted in Shandong province, located in eastern China (Figure 4). In 
2018, Shandong province had a population of 100 million living in over 100 counties, 
approximately half of which are rural [131]. It is known as ‘the stockbreeding province 
without a prairie’ and it is the second largest province in China by population and the third 
largest by GDP. Agriculture is the main economic activity in the rural areas of Shandong 
province, and the total production of meat in 2015 was 12.5 million tonnes, including poultry 
(4.6 million tonnes), pork (3.8 million tonnes) and beef (146,000 tonnes) [161]. The 
economic, education and health indicators of rural areas in Shandong province are generally 
similar to other rural areas in eastern China [131,162], and it is commonly used to represent 
this region in studies [66,150,163]. 
 
 
Figure 4. Shandong province (adapted from [164])  
 
 
 
3.2 OVERVIEW OF STUDIES 
 
Table 3 includes an overview of the studies included in the thesis.
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Table 3. Overview of studies and their methods 
 
Paper Topic Study design Study population and data Study period Data analyses 
I 
• Antibiotic prescribing rates for 
common colds 
• Doctors’ knowledge and 
attitudes towards antibiotic use 
• Retrospective 
observational  
• Cross-sectional survey 
 
• 8,400 outpatient 
prescriptions from 30 
healthcare facilities 
• 188 doctors working at 
healthcare facilities 
September – 
October 2012 
• Frequencies 
• Chi-squared tests 
II Variations in antibiotic prescribing among village doctors Prospective observational 
• 14,471 outpatient 
prescriptions from eight 
village clinics 
January 2015 
– June 2017 
• Frequencies 
• Kruskal-Wallis H-test 
• Mann-Whitney U-tests 
• Pearson correlation 
III 
Rural residents’ knowledge, 
attitudes and practices concerning 
antibiotic use and resistance 
Cross-sectional survey 
• 769 adult rural residents 
• Medicines stored in 
households for humans 
July 2015 
• Frequencies 
• Chi-squared tests 
• Multivariable logistic 
regression 
IV 
Backyard pig farmers’ knowledge, 
attitudes and practices concerning 
antibiotic use in pigs 
Cross-sectional survey 
• 271 adult rural residents 
with backyard pig farms 
• Medicines stored in 
backyard farms for pigs 
July 2015 
• Frequencies 
• Chi-squared tests 
• Univariate logistic 
regression 
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3.2.1 Study sites 
Paper I was conducted at healthcare facilities in three counties that had around 2.5 million 
inhabitants in 2012. These counties were selected based on geographic location and feasibility 
of the study, and to be representative of rural Shandong province. In each county, one county 
hospital, three township health centres and six village clinics were included (Figure 5). 
 
Figure 5. Selection of sites and healthcare facilities for Paper I (adapted from [116]) 
 
Papers II, III and IV were conducted in villages around a single town in one county, as part 
of the baseline data collection for a large interdisciplinary research programme called the 
Sino-Swedish integrated multi-sectoral partnership for antibiotic resistance containment 
(IMPACT) [161]. The study area was pragmatically selected based on the presence of local 
infrastructural support needed to coordinate all parts of the research programme (including 
baseline assessment; a pilot package of interventions delivered over a one-year period; and 
repeated data collection), and on the area being broadly representative of rural Shandong 
province. Papers III and IV took place in twelve villages located around the central town. 
These twelve villages were selected from seventeen possible villages using background data 
collected by the local Center for Disease Control and Prevention (CDC) so as to maximise: 
(i) the number of included backyard pig farms; and (ii) villages that had human healthcare 
clinics. The twelve villages contained between 100 and 350 households, of which 10-20% had 
backyard pig farms (similar to the national average [150]). Paper II took place in the eight 
village clinics that served these twelve villages, with some of the clinics being shared between 
villages. 
 
3.2.2 Study design and data collection 
Paper I included a cross-sectional survey of 188 doctors working at the thirty selected 
healthcare facilities in October 2012, and an analysis of outpatient prescriptions sampled 
from the same facilities over the preceding month. The questionnaire concerned knowledge 
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and attitudes towards antibiotic prescribing, particularly in the context of patients with the 
common cold, and it was developed jointly between collaborators in Sweden and China. All 
doctors working at the selected village clinics and township health centres, and at the county 
hospitals in the departments of internal medicine, surgery, paediatrics and obstetrics & 
gynaecology, were invited to participate. 
 
All available outpatient prescriptions were collected from the selected township health 
centres and village clinics for the month of September 2012. There was a much higher number 
of prescriptions at the county hospitals, so a systematic random sampling method was used 
to generate a maximum of 200 sample outpatient prescriptions from each department. Each 
prescription included the patient’s name, sex, age, diagnosis, medicines prescribed and their 
costs. The name of the prescriber was not collected for individual prescriptions. 
 
Data collection was carried out by ten master’s programme students and researchers from 
the Center for Health Management and Policy at Shandong University. 
 
Paper II was a prospective observational study in which 14,471 prescriptions were sampled 
over a 2.5 year period from the eight village clinics. The prescriptions of all village clinics in 
the study region are included in an e-prescription system that records the patient’s name, sex, 
age, date of visit, diagnosis, medicines prescribed, total cost for the visit, and the name of the 
doctor. For each village clinic a target of 60 prescriptions per month (from an average total 
of around 300) were collected using a random sampling method in which every fifth 
consecutive prescription was selected, beginning with a randomly generated number between 
1 and 10. The prescription details were exported individually from the e-prescription system 
in XPS format and entered into a Microsoft Excel database. In addition, in July 2015 the 
village doctors working at the clinics completed a short questionnaire concerning their socio-
demographic information (gender, age, years of medical practice). 
 
Papers III and IV were cross-sectional questionnaire surveys among adult rural residents 
living in the twelve villages included in the IMPACT research programme. The background 
data collected by the CDC was used to select individual households to invite to join the study, 
using a multistage sampling procedure: first, in each village up to 35 households with 
backyard pig farms (defined as containing at least one, but not more than 49 pigs) were 
randomly selected; if a village had fewer than 35 household backyard pig farms, all were 
selected. Second, the remaining number of households needed to produce a total of 65 
households per village were selected from all households without backyard pig farms, using 
a matched sampling method based on the number of household residents. 
 
The questionnaires were developed by experts in clinical medicine, public health, animal 
health and rural Chinese healthcare systems. Insights gained from four focus group 
discussions held in other villages in the study region earlier in 2015 were also used. The 
questionnaire (Appendix 1) included 95 items, including socio-demographics; health status; 
and knowledge, attitudes and practices towards antibiotic use and antibiotic resistance. Of 
the 769 rural residents who participated in the questionnaire (Paper III), 271 had pigs in a 
backyard pig farm at the time of the study. These respondents were asked additional 
questions about their knowledge, attitudes and practices towards antibiotic use in their pigs 
(Paper IV). In addition, respondents were asked to show data collectors which medicines 
they were storing in their households for use in humans and in pigs (Paper III and IV). For 
each medicine observed, the data collectors recorded the name and whether the respondent 
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thought it was an antibiotic. The questionnaires were developed in English, translated into 
Mandarin Chinese, piloted in ten households, revised, and back-translated into English. 
 
Households were visited in July 2015, and one resident per household was interviewed by a 
data collector. For households with backyard pig farms, the person who worked most closely 
with the pigs was prioritised to be invited. The data collectors were all students studying 
human or animal healthcare courses at master’s level at local collaborating universities and 
they attended a training day on interviewing skills, which included practising using the 
questionnaire tool. The questionnaire data were double-entered in Microsoft Access in 
simplified Chinese, translated into English, and exported into a Microsoft Excel database. 
 
3.2.3 Data management and analyses 
Coding of prescribed medicines (Papers I and II) and stored medicines (Papers III and IV) 
All antibiotics were coded according to the Anatomical Therapeutic Chemical (ATC) 
classification system [165] or ATCvet [166], and categorised by class and substance. In 
Papers II-IV, other types of medicine were also coded into single high-level categories: anti-
inflammatories and analgesic medicines; traditional Chinese medicines; anti-parasitics; and 
other medicines (i.e. medicines that could not be identified or that did not belong to any of 
the other categories). 
 
Coding of diagnoses (Papers I and II) 
For Paper I, all prescriptions containing a single diagnosis of “Gan mao” (common cold) 
were identified and included in further analyses. For Paper II, all unique diagnoses were 
translated from Chinese into English and coded where possible according to the International 
Classification of Diseases, 10th Revision (ICD-10) by an independent researcher. A category 
of likely viral acute upper respiratory tract infections (AURI) was created by grouping two 
diagnoses: J00 (acute nasopharyngitis [common cold]) and J06.9 (acute upper respiratory 
infection, unspecified). 
 
Grouping of prescribers and prescriptions (Papers I and II) 
For Paper I, comparisons were predominantly made between the different levels of 
healthcare facility (i.e. village clinic, township health centre and county hospital). For Paper 
II, both aggregate and individual prescriber-level analyses were conducted. The prescriber-
level analyses were limited to doctors with ≥50 prescriptions containing a diagnosis of likely 
viral AURI during the study period. An error was identified in the coding of one of the 
doctors responsible for prescriptions at village clinic 1, so all 433 prescriptions from this clinic 
were excluded from the prescriber-level analyses.  
 
Grouping of rural residents (Papers III and IV) 
For Paper III, participants were divided into two groups to assess the impact of experience 
with backyard pig farms on knowledge, attitudes and practices concerning antibiotic use in 
humans: “Backyard pig farmers” was used to collectively refer to the 330 participants who 
either had a backyard pig farm at the time of the study (271 participants) or within the 
previous five years (59 participants). The 439 “Other residents” were considered to not have 
any recent experience of backyard pig farming. Since Paper IV focused on respondents’ 
current practices in their backyard pig farms, it only included the 271 participants that had 
pigs at the time of study. 
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3.2.3.1 Statistical analyses 
Analyses were conducted in Excel, SPSS, Stata and R. All studies include descriptive analyses, 
such as frequencies and percentages for categorical variables, and mean and standard 
deviations for continuous variables. All statistical tests were two-tailed and were considered 
statistically significant if p < 0.05. 
 
For Paper I, categorical data were compared using chi-square tests, with comparisons made 
against village clinics. 
 
For Paper II, antibiotic prescribing patterns were analysed for village doctors using three 
indicators: 
a) antibiotic prescribing rate (APR) = number of prescriptions including at least one 
antibiotic / total number of prescriptions X 100% 
b) multiple antibiotics prescribing rate (MPR) = number of prescriptions including at least 
two antibiotics with different ATC codes / total number of prescriptions including at least 
one antibiotic X 100% 
c) parenteral antibiotics prescribing rate (PAPR) = number of prescriptions including at least 
one parenteral antibiotic / total number of prescriptions including at least one antibiotic X 
100% 
 
The Kruskal-Wallis H-test was used to assess whether there were statistically significant 
variations between the individual doctors in terms of antibiotic prescribing rates for likely 
viral AURIs [119]. Pairwise Mann-Whitney U-tests were used post-hoc to assess for 
differences in all pairwise comparisons between doctors, using the Benjamini-Hochberg 
procedure [167] to control the false discovery rate for multiple comparisons. Comparisons 
were also made against antibiotic prescribing quality indicators developed in Europe [168] 
for a subset of clinical diagnoses and patient age groups. 
 
For Paper III, a multivariable logistic regression model was used to identify socio-
demographic factors associated with knowing what antibiotics are, and with correctly 
identifying antibiotics from a list of medicines. 
 
For Paper IV, adjusted odds ratios were calculated to identify factors associated with 
household storage of at least one antibiotic for use in pigs. Independent variables included 
socio-demographic and farm characteristics, as well as knowledge, attitudes and practices 
towards antibiotic use in pigs. Adjustments were made for the sex, age and education level of 
respondent, but there was no attempt to adjust for clustering at the village level. 
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4 ETHICAL CONSIDERATIONS 
 
Ethical approval was obtained for Paper I from the School of Public Health, Shandong 
University, China (permit number 20111202). Ethical approval was obtained for Papers II-
IV from the first Affiliated Hospital, College of Medicine, Zhejiang University, China 
(reference numbers 2015#185 and 2015#283). 
 
Individual participation in all studies was voluntary, and informed consent was obtained 
from participants immediately prior to their responding to questionnaires. Consent was 
given in writing if possible (otherwise verbally), and participants were made aware that they 
could withdraw at any point without negative consequences. 
 
The following are reflections according to four common medical ethical principles [169]. 
 
Doing good 
A central purpose of the studies in this thesis is to develop an understanding of the local 
context of antibiotic use and its determinants in order to design interventions to improve 
how antibiotics are used. It is possible that our educational interventions will help the study 
participants to improve certain practices (e.g. hand washing) which could reduce the 
incidence of infectious diseases and spread of resistant bacteria, thereby directly benefiting 
them. If these pilot interventions are successful, they may be scaled up throughout other areas 
in rural China. 
 
Do no harm 
Our studies are unlikely to have caused significant harm to participants, but there will have 
been some costs from participating. For example, rural residents spent approximately one 
hour answering the questionnaires in Papers III and IV, which meant that they could not 
work during this time. The majority of participants were farmers who looked after their own 
animals and vegetables, so most are unlikely to have directly lost income through 
participating. All participants were given a small gift (washing powder). 
 
Some of the questions in the surveys in Papers III and IV asked for sensitive information, 
such as income, recent illnesses, and household storage of medicines. Similarly, the 
prescriptions collected from healthcare facilities in Papers I and II included doctors’ names, 
patients’ names, and clinical diagnoses. We informed participants that data would be stored 
confidentially and that there would be no judgments or consequences for them based on their 
individual responses. We strove to maintain confidentiality by replacing names with codes in 
the databases to de-identify individual participants, and further by limiting the sharing of 
data files. Only anonymised data were analysed in Sweden. 
 
Respect autonomy 
The studies included in this thesis may have impacted on the autonomy of individuals, in 
particular in the broader context of the research programme in which they were situated. 
After the baseline data collection presented in Papers III and IV, half of the participants were 
allocated to the intervention group for a pilot package of interventions to improve antibiotic 
use and hygiene practices. These interventions required a time investment from the 
individuals, for example, attending quarterly presentations at a village clinic and reading a 
booklet. Participation was voluntary for all intervention components, but there is cultural 
pressure placed on individuals to participate, and this explains why response rates in Chinese 
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studies (and other Asian countries) are often extremely high. For example, the participants 
were invited to join the study by an administrator in the village, and this person was “higher” 
in the social hierarchy than they are, so it could have been hard for them to decline. To 
address this, we routinely emphasised during data collection that participation was voluntary 
and that participants could withdraw without negative consequences. 
 
Justice 
We used scientific objectives to determine which healthcare facilities and individuals would 
be selected for our studies, and these objectives were articulated in the publications resulting 
from the research. For example, in Papers III and IV we purposefully over-sampled rural 
residents in the study villages who had backyard pig farms, in order to assess differences in 
the knowledge, attitudes and practices concerning antibiotics between residents with and 
without backyard pig farms, and in order to include a sufficient number of households with 
backyard pig farms for the pilot interventions. Overall, our research findings are intended to 
be of benefit for all rural residents, not any particular privileged groups. 
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5 MAIN FINDINGS 
5.1 ANTIBIOTIC PRESCRIBING AT HEALTHCARE FACILITIES 
5.1.1 What are the characteristics of the doctors who work at the healthcare 
facilities? 
Table 4 summarises the sex, age and work experiences of the doctors who replied to the 
questionnaire in Paper I, and who worked at the village clinics where prescriptions were 
sampled in Paper II. A bachelor’s degree was held by 77% of the doctors working at the 
county hospitals, 33% of the doctors at the township health centres, and 0% of the village 
doctors at village clinics in Paper I. Seventeen per cent of the village doctors had a junior high 
school education and 83% had a senior high school education at the village clinics included 
in Paper II. 
 
Table 4. Sex, age and working experiences of doctors at selected healthcare facilities 
 Paper I Paper II 
 County hospital Township health centre Village clinic Village clinic 
No. of doctors 60 98 30 23 
Male (n (%)) 26 (43) 49 (50) 22 (73) 19 (83) 
Mean age (years) 35 36 48 52 
Mean work 
experience (years) 11 14 26 32 
 
5.1.2 What conditions are doctors prescribing antibiotics for? 
Overall, 40.3% of prescriptions (5833/14471) from village clinics in Paper II contained one 
or more antibiotics. Respiratory tract infections accounted for 68.4% (3991/5833) and 
gastrointestinal conditions for 14.0% (815/5833) of all prescriptions containing at least one 
antibiotic (Table 5). A total of 5,177 prescriptions were categorised as likely viral acute upper 
respiratory tract infections, and 62.5% (3237/5177) of these prescriptions contained at least 
one antibiotic, accounting for 55.5% (3237/5833) of all antibiotic-containing prescriptions.
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Table 5. Infection-related diagnoses and antibiotic prescription rates at village clinics in Paper II 
   Antibiotic prescribing rate 
Body system 
(No. of prescriptions) Diagnosis ICD-10 code n/N % 
Respiratory (6183) Acute nasopharyngitis [common cold]+ J00 3034/4938 61.4 
 Bronchitis* J40 408/522 78.2 
 Acute upper respiratory infection+ J06.9 203/239 84.9 
 Acute pharyngitis J02.9 160/190 84.2 
 Acute tonsillitis J03.9 68/73 93.2 
 Rhinitis* NA 31/67 46.3 
 Cough NA 23/65 35.4 
 Pneumonia J18 40/51 78.4 
 Bronchopneumonia J18.0 15/19 78.9 
 Acute laryngopharyngitis J06.0 8/14 57.1 
Gastrointestinal (1642) Gastritis K29.7 258/856 30.1 
 Gastroenteritis A09 496/717 69.2 
 Diarrhoea NA 61/69 88.4 
Dental (222) Chronic periodontitis K05.3 100/131 76.3 
 Gingivitis and periodontal diseases K05 61/72 84.7 
 Pulpitis K04.0 19/19 100.0 
Urogenital (84) Inflammatory disease of prostate N41.9 23/45 51.1 
 Urethritis and urethral syndrome N34 23/24 95.8 
 Urinary tract infection N39.0 15/15 100.0 
Eye (101) Conjunctivitis H10 9/101 8.9 
Ear (11) Otitis media H66.9 7/11 63.6 
Footnote: *Not specified as acute or chronic; +Categorised as likely viral acute upper respiratory tract infections; NA = no ICD-10 code allocated
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Nineteen percent of prescriptions (1590/8400) collected at the healthcare facilities in Paper I 
contained a single diagnosis of common cold. Over half of these common cold prescriptions 
(55%, 869/1590) included at least one antibiotic. Table 6 summarises the antibiotic 
prescribing rates for the common cold across healthcare facilities in Paper I and at village 
clinics for likely viral AURIs in Paper II. 
 
Table 6. Antibiotic prescribing rates at selected healthcare facilities for common cold 
(Paper I) and likely viral acute upper respiratory tract infections (Paper II) 
 Paper I Paper II 
 CH THC VC Total VC 
Total no. of prescriptions 
sampled at facilities 1303 4799 2298 8400 14471 
Prescriptions for common cold 
or likely viral AURI (n (%))  122 (9) 839 (17) 629 (17) 1590 (19) 5177 (36) 
Antibiotic prescribing rate for 
common cold or likely viral 
AURI (n (%)) 
57 (47) 366 (44) 446 (71) 869 (55) 3237 (63) 
Footnote: CH = County hospital; THC = Township health centre; VC = Village clinic; AURI = acute 
upper respiratory tract infections 
 
5.1.3 Which antibiotics are being prescribed for AURIs? 
Similar classes of antibiotics were prescribed for common colds at the healthcare facilities in 
Papers I and for likely viral AURIs at village clinics in Paper II (Table 7), with the three most 
common classes being identical (J01D Other beta-lactam antibacterials; J01F Macrolides, 
lincosamides and streptogramins, J01C Beta-lactam antibacterials, penicillins). The mean 
number of antibiotics on antibiotic-containing prescriptions for common cold diagnoses at 
healthcare facilities in Paper I was 1.12, and the mean number for likely viral AURI diagnoses 
at village clinics in Paper II was 1.18. A quarter of the prescriptions for likely viral AURI 
diagnoses in Paper II included at least one parenteral antibiotic (24.3%, 785/3237). 
 
Table 7. Antibiotic classes prescribed at selected healthcare facilities for common cold 
(Paper I) and likely viral acute upper respiratory tract infections (Paper II) 
 Paper I Paper II 
 CH (n (%)) 
THC 
(n (%)) 
VC 
(n (%)) 
Total 
(n (%)) 
VC 
(n (%)) 
J01D Other beta-lactam antibacterials 22 (38) 156 (37) 210 (43) 388 (40) 1130 (30) 
J01F Macrolides, lincosamides and 
streptogramins 31 (53) 158 (37) 145 (29) 334 (34) 859 (22) 
J01C Beta-lactam antibacterials, 
penicillins 3 (5) 76 (18) 77 (16) 156 (16) 1153 (30) 
J01M Quinolone antibacterials 1 (2) 14 (3) 30 (6) 45 (5) 443 (12) 
J01X Other antibacterials 1 (2) 18 (4) 18 (4) 37 (4) 63 (2) 
J01E Sulfonamides and trimethoprim 0 (0) 3 (1) 6 (1) 9 (1) 1 (0) 
J01G Aminoglycoside antibacterials 0 (0) 1 (0) 7 (1) 8 (1) 166 (4) 
J01A Tetracyclines 0 (0) 1 (0) 0 (0) 1 (0) 3 (0) 
Footnote: CH = County hospital; THC = Township health centre; VC = Village clinic 
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5.1.4 How does the antibiotic prescribing compare with quality indicators? 
We compared antibiotic prescribing patterns for selected respiratory tract infections at the 
village clinics in Paper II against published European quality indicators [168] for outpatient 
antibiotic prescriptions (Table 8), and found that each indicator lay outside of the 
recommended range. 
 
Table 8. Antibiotic prescribing quality indicators for selected respiratory tract infections 
Diagnosis 
Patient 
age 
(years) 
APR 
n/N, (%) 
Antibiotic class prescribed 
J01M 
n/N, (%) 
J01CE 
n/N, (%) 
J01AA or J01CA 
n/N, (%) 
AURI  ≥2 3236/5172, (62.6) 436/3236, (13.5) 49/3236, (1.5) NA 
Target  0-20% 0-5% 80-100%  
Tonsillitis ≥2 68/73, (93.2) 15/68, (22.1) 2/68, (2.9) NA 
Target  0-20% 0-5% 80-100%  
Pneumonia 18-65  22/30, (73.3) 11/22, (50.0) NA 2/22, (12.8) 
Target  90-100% 0-5%  80-100% 
Footnote: Target ranges and categorisation of diagnoses is as previously published [168]; NA = no 
target set; APR = Antibiotic prescribing rate; AURI = Acute upper respiratory tract infection; J01M is 
the ATC code for Quinolone antibacterials, J01CE is the ATC code for Beta-lactamase sensitive 
penicillins, J01AA is the ATC code for Tetracyclines, J01CA is the ATC code for Penicillins with 
extended spectrum 
 
5.1.5 Is there significant variation between doctors? 
In Paper I we found that prescriptions with a diagnosis of the common cold were more likely 
to contain an antibiotic if they were from a village clinic than if they were from a township 
health centre or county hospital (71% vs. 44% and 47%, both p < 0.001). 
 
In Paper II we analysed individual village doctors’ prescribing patterns. We found that 
individual antibiotic prescribing rates for likely viral AURIs were relatively stable during the 
study period (i.e. highly correlated between 2015 and 2016 [r = 0.646]), but that there was 
widespread variation between prescribers (Figure 6). For likely viral AURIs, village doctors’ 
APRs ranged from 33% to 88%, multiple antibiotics prescribing rate (MPR) from 1% to 60%, 
and parenteral antibiotics prescribing rate (PAPR) from 3% to 62%. Village doctors’ APRs 
were positively correlated with their MPRs (r = 0.472, p = 0.048) and PAPRs (r = 0.544, p = 
0.02). 
 
The Kruskal-Wallis H-test showed that the variations in antibiotic prescribing rates for likely 
viral AURIs were statistically significant among the 18 prescribers (χ2 = 426, df = 17, p < 
0.001). Pairwise Mann–Whitney U-tests were used as post-hoc tests to assess for differences 
in all possible pairwise comparisons between prescribers. This involved 153 pairs of 
prescribers, and the difference was statistically significant in 93 of these. 
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Figure 6. Antibiotic prescribing rates for likely viral AURIs for individual doctors 
 
The village doctors each used between 11 and 21 different antibiotic agents for patients with 
diagnoses of likely viral AURIs. Amoxicillin was the most commonly prescribed agent for 
13/18 doctors; the most commonly prescribed agents for the remaining doctors included 
levofloxacin (two doctors), amikacin (one doctor), lincomycin (one doctor) and 
azithromycin (one doctor). For each doctor, their three most commonly prescribed antibiotic 
agents accounted for a mean of 64% (range 45% to 86%) of all the antibiotics they prescribed 
for likely viral AURIs. 
 
The village doctors also varied in the frequency with which they used other types of medicine 
for the patients that they diagnosed with likely viral AURIs (Figure 7). The most common 
choice was to use only an antibiotic (14/18 doctors); the four remaining doctors most 
commonly chose to use only analgesic or anti-inflammatory medicines. 
 
Figure 7. Prescribing of different medicine types for likely viral AURIs 
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We further compared selected indicators between the four village doctors with the highest 
(doctors 513, 412, 204 and 206) and lowest (doctors 203, 823, 308, 307) antibiotic prescribing 
rates for likely viral AURIs (Table 9). 
 
Table 9. Comparisons between high and low antibiotic prescriber groups 
Indicator High APR group (%) 
Low APR 
group (%) p-value 
Mean APR for likely viral AURIs 81.3 44.8 <0.001 
Mean MPR for likely viral AURIs 23.4 6.2 <0.001 
Mean PAPR for likely viral AURIs 33.6 10.7 <0.001 
Mean prescribing rate of only antibiotics for likely 
viral AURIs 40.6 18.3 <0.001 
Mean prescribing rate of only analgesics or anti-
inflammatory medicines for likely viral AURIs 10.6 26.2 <0.001 
Mean APR for AURI with potential bacterial causes*# 89.1 72.4 0.001 
Mean APR for gastritis, gastroenteritis and diarrhoea# 85.0 68.3 0.002 
Footnote: The high APR group contained the four village doctors with the highest antibiotic 
prescribing rates for likely viral AURIs, and the low APR group contained the four doctors with the 
lowest antibiotic prescribing rates for likely viral AURIs; APR = Antibiotic prescribing rate; MPR = 
Multiple antibiotics prescribing rate; PAPR = Parenteral antibiotics prescribing rate; *AURI with 
potential bacterial causes = prescriptions with a upper respiratory tract infection diagnosis of 
pharyngitis, tonsillitis or laryngopharyngitis; #These comparisons were restricted to village doctors in 
each group who had at least ten prescriptions containing a relevant diagnosis 
 
5.1.6 What are the knowledge and attitudes of doctors concerning antibiotic 
use? 
We examined the knowledge and attitudes concerning antibiotic use of doctors working at 
different healthcare facilities in Paper I. Most doctors did not think that newer antibiotics are 
more effective than older ones (98%, 182/186), nor that broad-spectrum antibiotics are more 
effective than narrow-spectrum ones (87%, 156/179). For patients with symptoms of the 
common cold, most doctors reported that that they would recommend drinking water and 
rest (80%, 150/187). Many doctors reported they would use analgesics, antipyretics or 
antivirals (67%, 126/187) whereas extremely few stated that they would prescribe antibiotics 
(2%, 3/187), and the majority reported that they would still not prescribe antibiotics if a 
patient insisted on receiving them (87%, 156/179). There were no major differences between 
doctors depending on the type of healthcare facility at which they worked. 
 
Most doctors (83%, 149/180) reported having participated in some training on antibiotic use 
since starting to work as a doctor. This was within the previous three years for almost all 
(97%, 112/116) of those who could provide dates for the training. Doctors who had attended 
training were less likely to report that they would give antibiotics to a patient with symptoms 
of the common cold who was demanding them (29% vs. 14%, p < 0.001). 
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5.2 SURVEYS AMONG RURAL RESIDENTS AND BACKYARD FARMERS 
5.2.1 What are the respondents’ socio-demographic characteristics? 
A total of 769 rural residents completed the questionnaire in Paper III, of whom 271 had 
backyard pig farms at the time and so also answered questions on antibiotic use in pigs (Paper 
IV). A further 59 of the 769 respondents had had a backyard pig farm within the previous 5 
years and so were considered to be “backyard pig farmers” when assessing the impact of 
backyard pig farming experience on knowledge, attitudes and practices towards antibiotic 
use. 
 
Table 10 summarises the socio-demographics of all respondents. The median age of the 
respondents was 54 years and the median number of household occupants was two. Backyard 
pig farmers were slightly younger on average than other residents and were more likely to 
have attended middle school. The median annual household income was 20,000 RMB (5,600 
Intl$), with an interquartile range of 8,000 to 30,000 RMB (2,200 to 8,400 Intl$). 
 
The median number of pigs in the backyard pig farms was 14. There were 29 households with 
more than 49 pigs at the time of the study, and responses from these households were 
included in all analyses. The backyard pig farmers had been raising pigs for a mean duration 
of 11 years. Eighteen percent (49/271) reported that they had had training about raising pigs, 
including from relatives, neighbours or friends (8%, 21/271), professional courses (7%, 
20/271), or a mixture of the two (3%, 8/271). 
 
Table 10. Socio-demographics of rural residents (Papers III and IV) 
Respondent socio-demographics (N = 769) n % 
Sex Male 450 59 
Age ≤54 years old 407 53 
Residents in household Two or fewer residents 390 51 
Children in household One or more children under 5 years old 70 9 
Duration of formal education 0-6 years 435 57 
 7-9 years 261 34 
 ≥10 years 80 10 
Current occupation Household animal farmer 329 43 
 Household farmer (not animals) 351 46 
 Other 89 12 
Backyard pig farm characteristics (N= 271) 
Number of pigs ≤14 pigs 140 52 
Type of pigs raised A) Sows, with piglets raised to slaughter 164 61 
 B) Sows, with piglets that are sold after weaning 40 15 
 C) A mixture of A) and B) 42 15 
 D) Piglets that are bought and raised to slaughter 16 6 
 E) Other 9 3 
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5.2.2 What are rural residents’ knowledge and attitudes towards antibiotic 
use in humans? 
The majority of participants (70%, 542/769) stated that they did not know what antibiotics 
are, and a similar proportion (63%, 487/769) could not identify a single antibiotic from a list 
of commonly used medicines. In univariable analyses, backyard pig farmers were more likely 
to know what antibiotics are than other rural residents (36% vs. 25%, p < 0.001), and to 
identify at least two antibiotics on the medicines list (31% vs. 21%, p < 0.01). In multivariable 
analysis, respondents were more likely to report knowing what antibiotics are if they were 
male, under 54 years old or had higher levels of education (Table 11). 
 
Table 11. Socio-demographic factors associated with reporting knowing what antibiotics 
are in multivariable logistic regression 
Factor OR (95% CI) p-value 
Sex Male 2.56 (1.74 – 3.81) 0.001 
Age ≤54 years old 3.04 (2.08 – 4.47) <0.001 
Duration of formal education 0-6 years 1 (Reference) <0.001 
 7-9 years 1.20 (0.70 – 2.04) 0.51 
 ≥10 years 3.55 (2.05 – 6.17) <0.001 
Backyard pig farm now or in past five years Yes 1.39 (0.98 – 1.97) 0.06 
Footnote: OR = odds ratio 
 
Participants were asked how often they thought antibiotics are needed for certain common 
conditions in humans. Differences existed between backyard pig farmers and other residents 
(Table 11). Residents with higher education levels and higher household incomes were more 
likely to correctly think that antibiotics are less often or never needed for the common cold 
(Figure 8). 
 
Table 11. Perceived needs for antibiotics for common conditions in humans 
Conditions 
Always or usually needs antibiotics 
p-value Backyard pig farmers  
N=330 
(n (%)) 
Other residents 
N = 439 
(n (%)) 
Common cold 99 (30) 105 (24) 0.09 
Sore throat 102 (31) 101 (23) 0.02 
Pneumonia 106 (32) 92 (21) <0.001 
Urinary tract infection 86 (26) 70 (16) 0.001 
Hypertension 20 (6) 26 (6) 1.0 
Diabetes 20 (6) 18 (4) 0.28 
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Figure 8. Variations between education and income quartile groups in how often 
antibiotics are perceived to be needed for the common cold 
Footnote: Q1 = >30,000 RMB/year; Q2 = 20,001 to 30,000 RMB/year; Q3 = 8,001 to 20,000 RMB/year; 
Q4 = ≤8,000 RMB/year 
 
5.2.3 What are backyard pig farmers’ knowledge and attitudes towards 
antibiotic use in pigs? 
Backyard pig farmers were asked to suggest up to two pig diseases that they thought should 
normally be treated with antibiotics. Thirty percent of participants (80/271) provided 
suggestions. The most common answers were diarrhoea (75%, 60/80) and respiratory tract 
infections (29%, 23/80). Other responses included foot and mouth disease (19%, 15/80), 
when a pig stops eating its feed (3%, 2/80), and bacterial infections (3%, 2/80). Figure 9 shows 
participants’ attitudes towards using antibiotics in pigs on their farms. 
Figure 9. Backyard pig farmers’ attitudes towards using antibiotics on their farms 
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5.2.4 What knowledge and attitudes do rural residents have towards 
antibiotic resistance? 
Rural residents were equally likely to believe that bacteria can become resistant to antibiotics 
(26%, 201/769) as they were to think that humans (29%, 220/769) or animals (27%, 210/769) 
can become resistant to antibiotics. Just under a fifth of participants (19%, 145/769) felt that 
their own actions were important for controlling antibiotic resistance. Participants were 
much more likely to think that their individual practices were important if they had earlier 
reported knowing what antibiotics are and had also correctly identified two antibiotics on the 
list of medicines (49% vs. 12% for other participants, p < 0.001). 
 
5.2.5 How are rural residents using antibiotics in humans? 
Thirty-one percent of participants (238/769) stated that they had bought antibiotics for 
human use from a pharmacy during the previous year. Most of these respondents (85%, 
202/238) reported that they did not have a prescription for at least one of the antibiotics that 
they had purchased. A half of all respondents (48%, 372/769) reported that they had stored 
leftover antibiotics in the previous year, and almost all (92%, 343/372) had either already used 
or planned to use these stored antibiotics. 
 
5.2.6 How are backyard pig farmers using antibiotics in pigs? 
Participants’ self-reported practices towards antibiotic use for their pigs are shown Table 12. 
Thirty percent (82/271) of backyard pig farmers reported that they had bought antibiotics in 
the previous year without first speaking with a veterinarian. 
 
Table 12. Backyard pig farmers’ self-reported practices towards antibiotic use 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Footnote: *Multiple responses could be selected. 
 
Practices n % 
I use antibiotics:   
     Always or often in feed to keep pigs healthy and prevent diseases 48 18 
     For all pigs in a pen when some are sick 75 28 
     Only in pigs that are showing disease 137 50 
     No response provided 11 4 
When my pigs are sick, I seek advice from:* 
  
     A veterinarian  163  60  
     An animal pharmacy  56  21  
     Other farmers  70  26  
     Nobody  45  16 
I usually buy antibiotics for my pigs from:*   
     A veterinarian 117 43 
     An animal pharmacy 157 58 
     A human pharmacy 4 2 
     Other 20 7 
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5.2.7 Are rural residents storing antibiotics in their households? 
Rural residents were asked to show data collectors which medicines they were storing in their 
households for human use and for pig use (Figure 10). 
 
Figure 10. Observed household storage rates of medicines for use in humans and pigs 
 
Antibiotics for human use were observed in 42% of households (321/769), with a median of 
one antibiotic stored per household (range one to six). Anti-inflammatory and analgesic 
medicines (46%, 357/769) and traditional Chinese medicines (48%, 371/769) were also 
frequently stored in households. The three most common antibiotic agents were J01CA04 
amoxicillin (present in 139 households), J01DB01 cefalexin (58 households), and J01DB09 
cefradine (39 households). 
 
Antibiotics for use in pigs were observed in 31% of households with backyard pig farms 
(83/271), with a median of two antibiotics stored per household (range one to nine). 
Traditional Chinese medicines accounted for 23% of all stored medicines for use in pigs 
(81/358). Anti-parasitic medicines (8%, 29/358), anti-inflammatory and analgesic medicines 
(3%, 12/358), and other medicines (11%, 39/358) were also observed. The three most 
common antibiotic agents were (Q)J01CA04 amoxicillin (present in 20 households), 
(Q)J01FF02 lincomycin (20 households) and (Q)J01AA06 oxytetracycline (15 households) 
and (Q)J01BA90 florfenicol (15 households). 
 
Seventy percent of participants (226/321) from households in which antibiotics for human 
use were being stored were not aware that any of the medicines stored were antibiotics. 
Similarly, 55% of farmers (46/83) from backyard pig farms in which antibiotics were being 
stored were not aware that they were storing any antibiotics.  
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Table 13. Five most common antibiotic classes stored for use in humans and pigs 
ATC code Antibiotic class n % of stored antibiotics  
Antibiotics 
for human 
use 
(N = 526) 
J01D Other beta-lactam antibacterials 163 31 
J01C Beta-lactam antibacterials, penicillins 148 28 
J01M Quinolone antibacterials 73 14 
J01F Macrolides, lincosamides and streptogramins 65 12 
J01X Other antibacterials 28 5 
Antibiotics 
for pig use 
(N = 197) 
(Q)J01C Beta-lactam antibacterials, penicillins 37 19 
(Q)J01F Macrolides, lincosamides and streptogramins 28 14 
(Q)J01M Quinolone antibacterials 25 12 
(Q)J01A Tetracyclines 22 11 
(Q)J01D Other beta-lactam antibiotics 19 10 
 
5.2.8 Is there an association between backyard pig farmers’ knowledge, 
attitudes and practices towards antibiotic use in humans and their 
knowledge, attitudes and practices towards antibiotic use in pigs? 
Backyard pig farmers who stated that they always or often add antibiotics into their pig feed 
were more likely to believe that antibiotics can prevent common colds in humans from 
becoming more a severe disease such as pneumonia (52% vs. 32% for the group of farmers 
who reported only using antibiotics if their pigs have signs of disease, p < 0.001). Backyard 
pig farmers who reported that they know when their pigs need medications were more likely 
than other farmers to expect a doctor to prescribe them antibiotics when they feel they are 
needed (38% vs. 24%, p < 0.001). 
 
Backyard pig farmers who reported that they had bought antibiotics in the previous twelve 
months without consulting a veterinarian were more likely than other farmers to report 
having bought antibiotics for human use at a pharmacy in the previous year without a 
prescription (49% vs. 25%, p < 0.001). Backyard pig farmers who believed it was good to store 
leftover antibiotics for pig use were more likely to be observed to be storing antibiotics for 
use in pigs (41% vs. 20%, p < 0.001) and also for use in humans (47% vs. 32%, p < 0.01). There 
was also a trend for farmers who were observed to be storing antibiotics for use in pigs to be 
more likely than other farmers to be storing antibiotics for use in humans (48% vs. 35%, p = 
0.06).
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6 DISCUSSION 
 
The aim of the thesis was to assess how antibiotics are being used for humans and on 
backyard pig farms in a rural region in China. This was addressed through studies of 
antibiotic prescribing at healthcare facilities, and surveys of the knowledge, attitudes and 
practices of doctors, rural residents and backyard pig farmers. 
 
The main findings are: 
1. Doctors, rural residents and backyard pig farmers are often misusing and overusing 
antibiotics 
2. There is significant variation in the antibiotic prescribing practices of individual doctors 
and between healthcare facilities 
3. Doctors have gaps between their knowledge and attitudes about rational antibiotic use, 
and their actual practices 
4. Rural residents and backyard pig farmers’ knowledge, attitudes and practices could lead 
to inappropriate antibiotic use 
5. Backyard pig farmers’ knowledge, attitudes and practices towards antibiotic use in 
humans and towards antibiotic use in pigs are interconnected 
  
The discussion begins with an interpretation of the findings, structured according to the 
research questions. This is followed by methodological considerations and lessons for 
assessing antibiotic use in other regions, as well as future recommendations for policy, 
practice and research. 
 
6.1 INTERPRETATION OF FINDINGS 
6.1.1 Antibiotics are frequently being misused and overused 
6.1.1.1 Prescriptions at healthcare facilities 
In China, almost all outpatient encounters include a prescription, in part because this is a way 
in which reimbursements are calculated and administered. We found that 40% of 
prescriptions from village clinics in Paper II contained at least one antibiotic, implying that 
a large proportion of outpatient appointments result in antibiotic use. This rate is slightly 
lower than previously published studies for outpatients in China, which have tended to be 
around 50% [66,117,119,135]. The government set a target in 2012 for secondary level and 
higher hospitals to prescribe antibiotics for fewer than 20% of outpatient encounters 
[170,171], but there is currently no corresponding target for village clinics. Although 
variations in case mix and patient health-seeking behaviours mean that it is difficult to make 
international comparisons, the WHO has previously recommended that the antibiotic 
prescription rate for outpatient encounters should not be higher than 30% [172], which 
suggests that antibiotics are being overused in our study setting. 
 
We investigated which clinical diagnoses antibiotics were being prescribed for by village 
doctors in Paper II, in order to assess whether antibiotics are being used responsibly. 
Although antibiotics can be appropriate therapies for several of the diagnoses (for example, 
urinary tract infections, prostatitis), the vast majority of antibiotics were prescribed for 
conditions for which there is little evidence of benefit (for example, upper respiratory tract 
infections, diarrhoea). 
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We focussed in more detail on how antibiotics were being prescribed for the common cold 
(Paper I) and for likely viral acute upper respiratory tract infections (Paper II). These are 
self-limiting conditions caused by viruses, for which antibiotics have not been shown to have 
clinical benefit [173–175]. Prescribing antibiotics to patients for these conditions therefore 
leads to the intrinsic negative consequences of using antibiotics (effects on microbiome, risks 
of adverse events, increasing selection pressures for resistant bacteria [6,15,16]), without 
positive clinical benefit, and so is not considered to be a responsible use of antibiotics 
[50,173]. We found that an antibiotic was included on 55% of all prescriptions for the 
common cold at healthcare facilities in Paper I, and on 62.5% of all prescriptions for likely 
viral AURIs at village clinics in Paper II. These antibiotic prescribing rates are similar to 
previous studies in rural village clinics in western China [119] and Guanxi province in 
southern China [176], as well as to studies in rural India (81%) [177] and Malaysia (46%) 
[67], but are higher than rates observed in national-level studies in Sweden (8%), Belgium 
(19%) and Netherlands (38%) [178].  
 
The patterns of antibiotic classes prescribed at healthcare facilities were quite similar in 
Papers I and II, although the studies were conducted four years apart and in different areas 
in Shandong province. Broad-spectrum and critically important antibiotics were commonly 
prescribed, in keeping with overall consumption levels that were recently reported in 
Shandong province using procurement data [85], and similar to previous studies conducted 
in village clinics in western China [119]. In general, broad-spectrum antibiotics are 
considered to pose a greater selection pressure for resistant bacteria and have wider impacts 
on the microbiome. Prescribing broad-spectrum antibiotics for clinical conditions where 
antibiotics have not been shown to have a clinical benefit is a particularly irresponsible 
practice. All but one antibiotic prescribed for likely viral AURIs at village clinics in Paper II 
were either present on the national essential medicines list [145], or on the list of 
supplemental essential medicines available in Shandong province; cefixime did not feature 
on either of these lists and accounted for 1.6% of all antibiotics prescribed for likely viral 
AURIs during the study period. 
 
Outpatient antibiotic prescribing quality indicators have been developed in Europe to assess 
the decision to prescribe an antibiotic in specific clinical conditions, and the actual choice of 
antibiotic agent [168]. All of our results from the village clinics in Paper II lay outside of the 
recommended ranges. In particular, we found that the recommended narrow-spectrum 
J01CE beta-lactamase sensitive penicillins were rarely used (1.5% for acute upper respiratory 
tract infections, 2.9% for tonsillitis), whereas J01CA penicillins with an extended spectrum 
were used far more frequently. This finding is not unique to rural China: broad-spectrum 
penicillins such as amoxicillin are still commonly used worldwide for treatment of upper 
respiratory tract infections, with the notable exception of Scandinavian countries where 
narrower-spectrum penicillins are preferred [179]. 
 
Interestingly, we observed that antibiotics were used less frequently than recommended for 
adults diagnosed with pneumonia (73.3% compared with a target of 90-100% [168]). This 
potentially represents an underuse of antibiotics, but needs to be investigated further. We 
also found that urogenital infections and skin and soft tissue infections each accounted for 
less than 1% of all antibiotic prescriptions at the village clinics, whereas these conditions are 
typically the second and third most common reasons for antibiotic prescriptions in studies 
from highly developed countries [180]. In contrast, dental conditions were the third largest 
group of diagnoses for which antibiotics were prescribed in our study. This may reflect the 
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extreme paucity of dentists in rural China [143], and is potentially an important and under-
reported source of antibiotic overuse. 
6.1.1.2 Practices of rural residents 
We asked residents in twelve villages about their practices concerning antibiotics in Paper 
III, to assess whether they were using antibiotics responsibly. A quarter of respondents 
reported having bought antibiotics for human use at pharmacies without a prescription in 
the previous year. This is a behaviour that can easily lead to antibiotics being consumed when 
they are not clinically needed, or an inappropriate choice of antibiotic being used when they 
are clinically needed. Regulating over-the-counter accessibility of antibiotics is 
recommended in the WHO Global Action Plan, to the extent that it does not restrict access 
to effective therapy [4]. Since 2004, prescriptions have been legally required for obtaining 
antibiotics from pharmacies in China [61]. This regulation is incompletely enforced, 
however; a study in another province in China reported that 40% of parents had bought 
antibiotics without a prescription in the previous year [95]. Studies using simulated patient 
encounters in urban and rural pharmacies have also demonstrated that antibiotics are 
frequently dispensed by pharmacists without prescriptions, based on presentations of 
symptoms of clinical conditions for which they are not necessary (such as AURIs), and 
particularly if directly demanded by patients [181–183]. 
 
We found that household storage of antibiotics for human use was common, and similar to 
levels identified in previous studies in Asia [95,184]. The types of antibiotic stored were very 
similar to the patterns of antibiotics contained on prescriptions sampled from the village 
clinics serving the villages in which the rural residents live (Paper II), suggesting that the 
stored antibiotics may be leftover from earlier prescribed courses. Almost all participants had 
already used the stored antibiotics on a second occasion or planned to do so in the future. 
Self-treatment with leftover antibiotics is another behaviour that can easily lead to antibiotics 
being consumed when they are not clinically needed, or an inappropriate choice, dose or 
duration of antibiotic being used when they are needed [57,185]. 
6.1.1.3 Practices of backyard pig farmers 
We asked farmers about their practices concerning antibiotics on backyard pig farms in 
Paper IV. We found that nearly a fifth of farmers reported always or often adding antibiotics 
to their pigs’ feed to keep the pigs healthy, i.e. using antibiotics as growth promoters. This 
proportion is probably higher in reality, since three-quarters of farmers also reported using 
commercial feeds, and these may have contained antibiotics that the farmers were unaware 
of. It is currently still permitted to use antibiotics as growth promoters in China, although 
the use of specific antibiotics has been restricted in recent years, in particular those that are 
considered critically important for human health [134,154]. Using antibiotics as growth 
promoters may lead to small benefits in growth production rates, but it comes at the expense 
of exposing animals to large volumes of antibiotics throughout their lifespans, and increases 
their carriage of resistant bacteria [18,186]. This may in turn represent an important source 
of contamination of carcasses at slaughter [187], but the ultimate risk for human health 
remains unclear [188]. Nevertheless, using antibiotics as growth promoters has been banned 
in the European Union since 2006 [189], and the WHO Global Action Plan recommends that 
all Member States work to phase out their use worldwide [4]. 
 
A third of backyard pig farmers reported having bought antibiotics for their pigs in the 
previous year, without consulting with a veterinarian. This can lead to antibiotics being used 
when they are not clinically required, or an inappropriate choice, dose or duration of 
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antibiotic being used when they are needed. We found that storage of antibiotics in 
households for pig use was common, and many of the stored antibiotics are classified by the 
WHO as critically important for human medicine [190], for example macrolides and 
quinolones (the second and third most frequently stored classes of antibiotics). 
 
Household storage of antibiotics for pigs could be a less strong indicator of irrational use 
compared with storage of antibiotics for human use; it may be appropriate and financially 
beneficial for farmers to store bulk-purchased antibiotics for use under the guidance of a 
veterinarian. However, we found that backyard pig farmers who had stored antibiotics in 
their household were more likely than other farmers to report having purchased antibiotics 
in the previous year without consulting a veterinarian, which suggests that antibiotics are not 
being stored under their guidance. There was also a trend towards higher storage rates of 
antibiotics for pig use among farmers who reported always or often using antibiotics as 
growth promoters, and among farmers who thought that antibiotics should be used whenever 
pigs stop eating their feed. Both of these behaviours are unnecessary uses of antibiotics. 
 
6.1.2 There is significant variation in the practices of doctors 
6.1.2.1 Variation between healthcare facility levels 
We compared antibiotic prescribing rates for common cold diagnoses at three different levels 
of healthcare facility in Paper I. Prescriptions were much more likely to contain an antibiotic 
if they were from village clinics, with township health centres and county hospitals having 
similar rates to each other. A previous systematic review similarly found that higher level 
hospitals in China tended to have lower overall antibiotic use rates for outpatients [135]. This 
might be considered a counterintuitive finding in terms of clinical need, since patients with 
more severe illnesses are generally referred (or self-refer) to higher level healthcare facilities. 
A possible explanation is that doctors in higher level healthcare centres are better at 
diagnosing and treating infections, leading to lower prescription rates of antibiotics for viral 
illnesses, and lower overall antibiotic consumption. As described earlier, the background 
educational levels of doctors normally vary across healthcare facilities in China. None of the 
village doctors in our studies had a bachelor’s degree, compared with almost half of the 
doctors at county hospitals and a third of the doctors at township health centres. Although 
most village doctors reported in Paper I having recently attended training on rational 
antibiotic use it is likely that such training does not fully compensate for underlying 
differences in the education of doctors. 
 
These variations in antibiotic prescribing rates between healthcare facility levels may also 
reinforce socioeconomic inequalities in healthcare. In general, the village clinics serve 
residents who live in the villages, whereas the township health centres and county hospitals 
serve people who live in more developed areas (such as towns), as well as those who live in 
villages but who are willing to travel further and to pay more for the care they receive. Choice 
of healthcare facility is at least partly related to patients’ socioeconomic status. Our results 
suggest that within rural areas, people living in poorer areas (villages) are more likely to be 
unnecessarily exposed to antibiotics for the common cold, through being more likely to 
attend lower level healthcare facilities where antibiotics are more frequently overused. 
6.1.2.2 Variations between individual doctors 
Our study design for Paper II enabled us to investigate variability in antibiotic prescribing at 
the prescriber-level whilst keeping several factors relatively constant: the villages served by 
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the village clinics were limited to a small geographical region and were quite homogeneous 
in terms of socioeconomic levels; the patient populations in the villages were likely to have 
had similar consultation behaviours when ill, particularly for a common diagnosis such as an 
AURI; the doctors all had the same medical qualifications and at least 14 years of clinical 
experience; the village clinics were all subject to the same regulations concerning antibiotic 
use and reimbursement systems [138,146]. It could be hypothesised that little variation would 
exist in the prescribing practices of the village doctors, given these similarities. Our results, 
however, revealed substantial differences between doctors in antibiotic prescribing rates for 
likely viral acute respiratory tract infections, as well as for the use of multiple antibiotics and 
injectable antibiotics. 
 
Few previous studies have assessed variations between individual prescribers, with most 
studies analysing aggregated data and presenting averages. A study in 2005 found that 
antibiotic prescribing rates for upper respiratory tract infections among 84 primary care 
doctors in the Netherlands ranged from 15% to 27% [191]. Among our considerably smaller 
group of 18 doctors, this rate ranged from 33% to 88%. 
 
Individuals who had higher antibiotic prescribing rates for likely viral AURIs were also more 
likely to prescribe multiple antibiotics and injectable antibiotics for these conditions. We 
found that the quartile of village doctors with the highest antibiotic prescribing rates for likely 
viral AURIs were more likely to prescribe antibiotics for diagnoses of gastritis, gastroenteritis 
and diarrhoea than the lowest quartile of antibiotic prescribers for likely viral AURIs. This 
suggests that for some village doctors, overuse of antibiotics is not limited to specific clinical 
conditions but may be a general pattern of behaviour. Uncertainty avoidance is a factor that 
has been linked with overuse of medicines, including antibiotics [65]. In keeping with this, 
these high antibiotic prescribers were also more likely than the low antibiotic prescribers to 
prescribe antibiotics for the subgroup of respiratory tract infections that have potential 
bacterial causes, i.e. where antibiotics are more likely to be clinically indicated. 
 
We also found significant variation within the high-prescriber group, demonstrating the 
additional information that can be gained from individual-level analyses: patients with likely 
viral acute respiratory tract infections who visited village doctors 513 and 412 were equally 
likely to be prescribed an antibiotic (mean antibiotic prescribing rate of 87%). However, those 
who visited doctor 513 were six times more likely to be prescribed two or more antibiotics, 
three times more likely to be prescribed a parenteral antibiotic, and a third less likely to be 
prescribed an analgesic or anti-inflammatory medicine; furthermore, the choice of antibiotic 
prescribed was likely to be an aminoglycoside, a third generation cephalosporin or a 
fluoroquinolone (all broad-spectrum antibiotics), compared with amoxicillin, a first-
generation cephalosporin, or a macrolide (slightly narrower-spectrum antibiotics).  
 
Individual-level analyses are often cautioned against due to the difficulties in accounting for 
variations in patient case mix. This is particularly relevant when attempting to compare 
studies conducted in settings where patients exhibit different health-seeking behaviours and 
have different patterns of co-morbidities. However, evidence is increasingly suggesting that 
differences in patient case mix may not explain a large amount of the variability in prescribing 
patterns for antibiotics [192]. Importantly, choosing to not investigate variations between 
individual prescribers causes us to subtly obscure the responsibility of the individual 
decision-maker, as well as the elevated risks that individual patients are exposed to when they 
consult with individuals who overuse antibiotics. Indeed, this is a compelling example of why 
antibiotic stewardship is often advocated to be viewed in terms of patient safety [193]. 
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Promisingly, a recent US study showed that monthly peer comparison of antibiotic 
prescribing rates, combined with baseline education, was able to reduce rates of unnecessary 
antibiotic prescribing among high prescribers for acute respiratory tract infections [194]. 
Similarly, a study in Anhui province, China, demonstrated that just-in-time information and 
individualised feedback to village doctors can improve their antibiotic prescribing practices 
for respiratory tract infections and gastrointestinal tract infections [195]. 
 
6.1.3 Knowledge and attitudes of doctors, rural residents and backyard pig 
farmers towards antibiotic use and resistance 
6.1.3.1 Doctors have gaps between their knowledge and attitudes and their actual practices 
We asked doctors at different healthcare facilities about their knowledge and attitudes 
towards antibiotic use in Paper I, using a limited set of questions. Their responses were 
consistent with using antibiotics responsibly. For example, most doctors reported that they 
did not believe that newer antibiotics are more effective than older ones, nor that broad-
spectrum antibiotics are more effective than narrow-spectrum ones. Concerning the use of 
antibiotics for patients with symptoms of the common cold, extremely few doctors reported 
that they would consider prescribing antibiotics, even when pressured by patients; most 
doctors said they would recommend using non-antibiotic measures instead. In practice, 
however, we found that at least one antibiotic was present on over half of all prescriptions for 
patients with a common cold diagnosis at the facilities these doctors worked in, and these 
were frequently broad-spectrum antibiotics. There is therefore a significant discrepancy 
between reported knowledge and attitudes, and actual practices. 
 
In a separate study [196], we interviewed fifteen of the village doctors who worked at the 
village clinics from which prescriptions were collected in Paper II. These doctors reported 
that patients frequently demand antibiotics, and that they would simply buy them at 
pharmacies if the doctors refused to prescribe them. Reynolds et al. previously carried out 
semi-structured interviews with doctors at healthcare facilities in another province in 
southern China [61]. Their findings suggested that doctors know that antibiotics are not 
needed for the common cold, but they often still prescribe them under the belief that they 
might speed recovery, and in response to patient expectations. A further driving factor for 
antibiotic overuse may be financial incentives: at the time of the study reported in Paper I, 
doctors were able to make a profit from prescriptions, and this may have stimulated over-
prescribing of antibiotics [137]. 
6.1.3.2 Rural residents and backyard pig farmers’ knowledge and attitudes may lead to 
inappropriate antibiotic use 
Overall, rural residents appeared to have low levels of knowledge about what antibiotics are 
and when they should be used, as well as about antibiotic resistance, as found in previous 
studies in China [95,124,125]. Over two-thirds of residents reported that they did not know 
what antibiotics are, and a large proportion responded “Don’t know” to questions concerning 
the need for antibiotics in common illnesses; these responses were also more frequent among 
respondents with lower education levels and from households with lower incomes. Rural 
residents more frequently thought that antibiotics are needed for infectious conditions 
(pneumonia, common cold) than for non-infectious conditions (hypertension). They did 
not, however, differentiate significantly between infections caused by bacteria, where 
antibiotics may be needed, and those caused by viruses, where they are not. A quarter of 
respondents thought that antibiotics were always or usually needed for a common cold, and 
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nearly a third thought antibiotics can prevent a common cold from becoming a more severe 
illness. We found similar over-expectations for antibiotics in another study in Shandong 
province, in which respondents commonly thought that antibiotics are needed when children 
have a stuffy nose (32%) or a sore throat (36%) [125]. It is possible that these over-
expectations for antibiotics are a result of the frequent prescribing of antibiotics by doctors 
for patients with AURIs, as seen in our prescription analyses (Papers I and II); it is also 
possible that patient expectations for antibiotics are influencing prescriber behaviour, and so 
are themselves a driver for antibiotic overuse [61,197]. 
 
We found that backyard pig farmers also had low levels of knowledge about antibiotic use in 
pigs. These knowledge levels are similar, however, to other studies conducted among animal 
farmers in low-and middle-income countries including Sudan [198], Ghana [199], Cambodia 
[200]. These low knowledge levels are not unexpected, since very few farmers reported having 
had any form of training on raising pigs, and only 10% had attended professional courses. 
Backyard pig farmers most likely gain their knowledge from conversations with other farmers 
and family members, and from their own practical work experience. Of note, only 30% of 
farmers were able to provide suggestions for which pig diseases usually require antibiotic 
treatment, with most responding “Don’t know”. The most frequently mentioned disease was 
diarrhoea. Several common diarrhoeal diseases in pigs are caused by bacteria (e.g. neonatal 
diarrhoea, weaning diarrhoea, swine dysentery and porcine proliferative enteritis). However, 
viruses are also a common cause of diarrhoea in pigs, so consulting a veterinarian to reach an 
aetiological diagnosis is important for deciding whether antibiotics are indicated, and if so, 
which antibiotic should be used [201]. Positively, the backyard pig farmers in our study had 
high trust levels in veterinarians, and most farmers did not consider it to be expensive to 
consult veterinarians. Despite this, 40% reported that they do not usually seek advice from 
veterinarians when their pigs are sick. 
 
Foot and mouth disease was the third most common suggestion by backyard pig farmers of 
a disease that requires antibiotic treatment. This is perhaps surprising since foot and mouth 
disease is a highly epidemic viral disease with strict national and international regulations, 
such as culling of affected animals, and vaccination of animals at nearby farms. It is possible 
that farmers are aware that injections are needed to prevent foot and mouth disease, but that 
they do not know that this is a vaccine, not an antibiotic. 
 
6.1.4 Backyard pig farmers’ knowledge, attitudes and practices towards 
antibiotic use in humans and antibiotic use in pigs are interconnected 
Due to their practical experience of treating pigs on their farms, we hypothesised that 
backyard pig farmers might have slightly different patterns of knowledge, attitudes and 
practices concerning antibiotic use in humans, compared with other residents. We found that 
backyard pig farmers were indeed more likely to report knowing what antibiotics are and to 
correctly identify antibiotics from the list of medicines commonly used in humans. Backyard 
pig farmers were also more likely to think that antibiotics are always or usually needed for 
specific infectious illnesses in humans. These differences remained significant after adjusting 
for socio-demographic differences (age, sex and education) between backyard pig farmers 
and other residents, as well as for self-reported knowing what antibiotics are. 
 
We also found that backyard pig farmers’ attitudes and practices towards medicine use in 
pigs had some parallels with their attitudes and practices towards medicine use in humans. 
For example, farmers who reported always adding antibiotics to pig feed to keep pigs healthy 
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were more likely to believe that antibiotics could have a prophylactic effect in humans 
(stopping a cold becoming more severe). Similarly, farmers who reported that they had 
bought antibiotics for their pigs in the previous year without speaking with a veterinarian 
were also more likely to report having bought antibiotics for themselves in the previous year 
without a prescription. We also found that farmers who thought it was good to store leftover 
antibiotics for pigs were more likely to be storing antibiotics for human use in their 
household. 
 
Together, these findings suggest that backyard pig farmers develop common attitudes 
towards antibiotic use that translate into similar behavioural patterns when using antibiotics 
in pigs and for themselves. Indeed, during a focus group discussion we held with backyard 
pig farmers in a nearby village, one participant said “It is basically the same between humans 
and pigs. If they have a fever, I use penicillin”. To our knowledge, such associations have not 
previously been investigated. They may be widely relevant, however, in the many other 
resource-limited settings where small-scale food animal production is common [39]. These 
associations highlight the importance of a One Health perspective, including recognising that 
interventions may have consequences across sectors: changing farmers’ antibiotic use 
practices on their backyard farms may affect how they use antibiotics for themselves, and vice 
versa. 
 
6.1.5 Antibiotics are not being used responsibly enough 
Overall, the work in this thesis strongly suggests that antibiotics are not being used 
responsibly enough for humans and on backyard pig farms in the study region. This is both 
in terms of individual uses of antibiotics, and in terms of the broader context in which 
antibiotics are being used [50]. We identified several individual practices of antibiotic overuse 
and misuse, including doctors prescribing antibiotics for conditions for which they are not 
necessary; rural residents using leftover antibiotics and obtaining antibiotics without 
prescriptions; and backyard pig farmers giving antibiotics to healthy pigs. The types of 
antibiotics that were being prescribed unnecessarily by doctors were frequently broad-
spectrum, as were the antibiotics stored in rural residents’ households that they reported to 
have self-treated with. Similarly, many of the antibiotics stored for use in pigs are considered 
to be critically important antibiotics for human medicine [190]. 
 
More broadly, rural residents and backyard pig farmers had poor knowledge of which 
conditions require antibiotics, yet antibiotics for use in both humans and pigs appeared to be 
readily accessible without needing to consult doctors or veterinarians. Doctors had access to 
training on antibiotics and appeared to know that antibiotics were not needed for common 
colds, yet no mechanisms were in place to help ensure that their practices reflected this 
knowledge. Furthermore, wide variations in prescribing rates and patterns were permitted to 
exist, and many doctors were underusing symptom-relieving alternatives to antibiotics for 
acute respiratory tract infections, such as anti-inflammatory and analgesic medicines. 
 
The specific consequences of the level of antibiotic overuse and misuse in the study region 
are unknown. However, as described earlier, these will likely include negative health and 
economic consequences for individuals and the healthcare system through being an 
inefficient use of resources and through unnecessarily exacerbating the burden of antibiotic 
resistance. Other parts of the IMPACT research programme from which Papers II-IV 
originated have demonstrated the high prevalence rates in the region of resistant bacteria in 
humans [202], animals [157,158] and the environment [159,160], as well as the common 
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presence of antibiotic residues in a number of water sources [203]. The data presented in this 
thesis on antibiotic use patterns, and the knowledge, attitudes and practices of doctors, rural 
residents and backyard pig farmers complement these data and contribute towards a more 
holistic One Health understanding of antibiotic use and resistance in the region. 
 
6.2 METHODOLOGICAL CONSIDERATIONS 
The studies in this thesis used two main methods: analyses of prescriptions from healthcare 
facilities (Papers I and II), and surveys of knowledge, attitudes and practices of doctors 
(Paper I), rural residents (Paper III) and backyard pig farmers (Paper IV). 
6.2.1 Analyses of prescriptions 
6.2.1.1 Strengths 
In Paper I we investigated how frequently antibiotics were prescribed for patients with the 
common cold at different types of rural healthcare facility. These facilities were selected from 
three different counties, in order to increase representativeness of rural Shandong province. 
Within each county, the same procedures were used for selecting participating facilities and 
for sampling prescriptions. Prescriptions were all collected over the same one-month period, 
to reduce the impact of seasonal variation in antibiotic prescribing rates on comparisons 
between the facilities. 
 
In Paper II we investigated how frequently village doctors prescribed antibiotics for likely 
viral acute upper respiratory tract infections, and how much variation there was between 
individual prescribers. The prescriptions contained the clinical diagnoses, the medicines 
prescribed and the doctors’ names, which allowed us to describe the prescribing patterns of 
individual doctors for specific clinical diagnoses, and to assess the use of antibiotics as well as 
other medicines (e.g. anti-inflammatory and analgesic medicines). We collected data over a 
long time period, and we made comparisons between years which showed that doctors’ 
practices were generally stable across the study period. We coded all clinical diagnoses 
according to ICD-10 codes to facilitate comparisons with other studies. We limited the 
prescriber-level analyses to doctors with ≥50 AURI prescriptions during the study period. 
6.2.1.2 Limitations 
Selection bias 
Selection biases are introduced when the study population does not represent the target 
population [204]. Healthcare facilities were selected from three different counties in 
Shandong province in Paper I; within each county, facilities were selected at random. 
Although we have no reasons to believe that the selected facilities differed substantially from 
others in rural Shandong province, we did not collect information on the size of the facilities 
or patient mixes, which might have allowed comparisons to be made. For Paper II, all village 
clinics within the study area were included. In both studies it is possible that patients attended 
healthcare facilities and received diagnoses, but were not given prescriptions; however, this 
would be very unusual in this setting, in part because prescriptions are a way in which 
reimbursements for healthcare expenditures are calculated and administered.   
 
Information bias 
Information biases are introduced during data collection when there are systematic 
differences in the way data on exposure or outcome are obtained from differing study groups 
[204]. We had no way to clinically validate the diagnoses included on the prescriptions in 
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Papers I and II, so it is possible that misclassifications occurred, and potentially at different 
rates between facilities. To focus on antibiotic overuse we used a very conservative definition 
for likely viral acute upper respiratory tract infections in Paper II, rather than including other 
acute upper respiratory tract infections which may be caused by bacteria (e.g. pharyngitis), 
and where antibiotic use is more likely to be warranted for a proportion of patients. These 
likely viral AURIs accounted for an average of 86% of all respiratory tract infection diagnoses 
in Paper II, but this ranged from 58% to 100% for individual doctors. This wide range 
suggests that there were variations in how village doctors classified infections, and/or in their 
diagnostic abilities. A recent study has highlighted variability in diagnostic ability as an 
important driver of unnecessary antibiotic prescriptions in clinics in rural China [205]. 
 
Additional limitations 
Our data sources were prescriptions; it is possible that there are systematic differences 
between the healthcare facilities and patient populations that affect the likelihood that a 
prescribed antibiotic is ultimately consumed. We used a few indicators that have been used 
in previous studies of antibiotic prescriptions. However, due to the formatting of the exported 
prescriptions, we were not easily able to assess the duration or dosing of antibiotics 
prescribed. We therefore could not express antibiotic use in terms of Defined Daily Doses, 
which would have enabled more accurate comparisons with international studies of 
antibiotic consumption intensity. We also did not have access to data that could account for 
variations in the workload of individual doctors, or to control for patient co-morbidities. A 
broader limitation to assessing antibiotic use on backyard pig farms in the study region was 
our complete inability to assess the prescribing patterns of veterinarians, due to a lack of 
access. Similarly, we were unable to involve pharmacies in our studies; these may have been 
able to provide complementary information on over-the-counter purchasing patterns for 
antibiotics for use in both humans and animals. 
 
6.2.2 Surveys of knowledge, attitudes and practices 
6.2.2.1 Strengths 
In Paper I we assessed doctors’ knowledge and attitudes towards antibiotic use. We had a 
very high participation rate with all doctors who were working on the day when the 
questionnaire was distributed at each facility completing the survey. 
 
In Papers III and IV we assessed rural residents’ and backyard pig farmers’ knowledge, 
attitudes and practices towards antibiotic use and resistance. A local administrator visited 
each selected household the day before data collection to remind residents that someone 
should be at home for the data collection visit. In total 769 responses were included (Paper 
III) from an original target of 780. Participants were interviewed in their own homes, which 
provided a more natural setting than in studies conducted at healthcare clinics. This also 
allowed us to directly observe storage of antibiotics and other medicines, rather than using 
self-reports with their potential for reporting bias, and further to assess if participants were 
aware that they were storing antibiotics. 
6.2.2.2 Limitations 
Selection bias 
For Paper I, the same biases as described above are relevant here. It should also be noted that 
respondents at the three included county hospitals were from the departments of internal 
medicine, surgery, paediatrics and obstetrics & gynaecology; these respondents were 
  49 
therefore more specialised, and their responses may be less directly comparable with the more 
generalist doctors working at township health centres and village clinics. 
 
For Papers III and IV, we purposefully over-sampled backyard pig farmers compared with 
their prevalence in the villages. We found differences between backyard pig farmers and rural 
residents without backyard farms, which suggests that for certain outcomes a weighted 
method of aggregating the responses from different participant types might be needed to 
most accurately represent these villages. We also ultimately included 29 households that had 
more than 49 pigs in a backyard farm at the time of data collection. We decided to still include 
these households in our analyses since almost all had fewer than 100 pigs, and there were no 
significant differences in a subgroup analysis. 
 
Information bias 
All of the surveys may have suffered from reporting and recall bias, as well as bias due to 
social expectations. Rural residents and backyard pig farmers may not have been willing to 
show which medicines they were storing in their households, but we have no reason to believe 
that they would specifically conceal storage of antibiotics. It is possible that medicines 
intended for use in other animals were shown and/or recorded by the data collectors in Paper 
IV, although respondents were asked to only show the medicines that they were storing for 
use in pigs. We did not record the locations or conditions in which medicines were stored, 
nor whether they were within their expiration dates. Data collection occurred at a single time 
point for Papers III and IV, and storage rates of antibiotics may have differed at other times 
in the year. 
 
Confounding 
The regression models presented in Papers III and IV may be subject to confounding, when 
an observed association is distorted because the exposure is correlated with another risk 
factor, which is in turn associated with the outcome, but independently of the exposure under 
investigation [204]. For example, residents’ knowledge of what antibiotics are (Paper III) and 
rates of storing antibiotics for pig use (Paper IV) could be related to household income, but 
this factor was not included in the regression models due to a high frequency of missing data. 
Of note, there did not appear to be any major clustering at the level of villages for responses 
to the knowledge, attitudes and practices questions in Papers III and IV. 
 
6.2.3 External validity of the studies 
External validity deals with the degree to which research findings can be generalised to other 
groups or populations [206]. We believe that our main findings described above are mostly 
transferrable to other parts of rural eastern China, to which our study region is broadly 
similar in terms of population socio-demographics and educational levels [131,207]. 
Shandong province has previously been used as a representative of eastern coastal and 
northern provinces both for studies involving backyard pig farms [150] and antibiotic use in 
human healthcare [66,163]. Within human healthcare, all rural areas are subject to the same 
regulations, such as the zero mark-up policy at village clinics and public primary care 
facilities. Backyard pig farms are quite homogenous, and previous studies in rural China have 
often collected data from a small number of sites [150,151]. 
 
Several specific results, for example in terms of the types of antibiotics stored, are likely to be 
less generalisable to other countries in the region. This is because the behaviours of doctors, 
residents and backyard pig farmers will likely be influenced by local antibiotic use regulations, 
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market availability of antibiotics, cultural health-care seeking patterns, and other economic 
factors. 
 
6.2.4 Lessons for assessing antibiotic use in other regions 
As antimicrobial resistance rates continue to rise, and as new antibiotic classes are yet to reach 
market availability, it is critical that we assess how we are using our existing antibiotics. The 
WHO Global Action Plan recognises this, and assessments of antibiotic consumption in 
humans and animals are commonly featured in countries’ National Action Plans on 
antimicrobial resistance [4,148,208]. To date, there have been very few examples of 
comprehensive assessments of antibiotic use and resistance within a single region 
[81,209,210], highlighting the substantial challenges involved in such work [80,211]. The 
results presented in this thesis, and the experiences involved in designing and conducting the 
studies [80], provide lessons that may be valuable for other regions. 
 
Purpose: A critical initial step is deciding on the purpose of assessing antibiotic use, since 
this directly affects which data should be collected, how it should be collected, and how it 
should be analysed. In resource-limited community settings where little existing data is 
available, purposes might include: identifying where the majority of antibiotics are being 
obtained (e.g. pharmacies vs. healthcare facilities; private vs. public healthcare facilities); 
identifying the most common clinical reasons for unnecessary and inappropriate antibiotic 
use; identifying how frequently antibiotics are being used in the absence of consultations with 
human or veterinary healthcare professionals. 
 
Coverage: In some countries, existing systems in human medicine are able to provide 
representative coverage of which antibiotics are being used and for which clinical diagnoses, 
at national levels [180]. Comparatively, equivalent systems are in veterinary medicine 
[79,208]. In resource-limited settings it may only be feasible to collect data in a small number 
of areas, and at a limited number of time points. Whilst these samples may not produce 
nationally representative consumption data, they may still produce valid insights into the 
reasons for overuse and misuse of antibiotics within a country, and these may actually be 
more relevant to improving antibiotic use than accurate consumption data. It may therefore 
be more strategic to invest in conducting high quality assessments at a small number of study 
sites than in attempting to capture overall antibiotic consumption across larger areas. 
 
Working across sectors: Cross-sectoral work is needed to understand the total antibiotic use 
within a region, and consequently the overall ecological pressure placed on bacteria [78,79]. 
This is particularly important for countries such as China where antibiotics that are originally 
manufactured for human use are frequently used in animals, either as growth promoters in 
feed, or for veterinary purposes [134]. Working across sectors may also help to identify 
strategic intervention points where antibiotic use can be improved in both humans and 
animals, such as limiting over-the-counter availability of antibiotics. 
 
Investigate variations: It is valuable to assess the extent of variations in antibiotic use 
practices. If there is little variation, then interventions to improve antibiotic use (such as 
education for doctors and the public) may be able to focus on a limited number of key 
messages and be widely applicable; if there are widespread variations, however, interventions 
may need to be much more targeted, such as individualised feedback to doctors on choices 
of antibiotic agents. Assessing variations can also help identify individuals and facilities that 
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consistently appear to be using antibiotics responsibly. A more in-depth follow-up with these 
“bright spots” may then help to identify barriers and facilitators to responsible antibiotic use. 
 
Include qualitative assessments: We conducted focus group discussions with residents 
before we designed the questionnaire used in Papers III and IV. This was an important phase 
to develop initial ideas about how and why rural residents might be overusing or misusing 
antibiotics, which we could then assess with a larger number of respondents. These focus 
group discussions were also helpful for developing the pilot interventions in the IMPACT 
research programme, such as highlighting the importance of patient expectations for 
antibiotics. Qualitative work with doctors can also be a useful way to further explore findings 
from quantitative assessments of antibiotic consumption, for example to find explanations 
for variations seen between prescribers. 
 
Involve the public: There can be a need to survey the public in settings where antibiotics are 
routinely accessed over-the-counter (for use in humans or in animals), because antibiotic 
consumption data from healthcare facilities may provide limited insights into total antibiotic 
consumption. Involving the public can also provide information about adherence to 
antibiotic courses prescribed by doctors and veterinarians, and on the frequency of self-
treatment with leftover antibiotics. 
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7 CONCLUSIONS 
 
The main conclusions to be drawn from the work in this thesis are: 
 
• Doctors, rural residents and backyard pig farmers in rural Shandong province are 
frequently overusing and misusing antibiotics. The majority of antibiotics prescribed at 
human healthcare facilities are prescribed for conditions that do not require them. In 
addition, rural residents are commonly acquiring antibiotics without prescriptions and 
using leftover antibiotics, and backyard pig farmers are often using antibiotics in healthy 
pigs when they are not needed. 
 
• There are widespread variations in the antibiotic prescribing practices of individual 
doctors and between healthcare facilities, within a relatively homogenous setting in rural 
Shandong province. This is a barrier to equitable access to healthcare, and the differences 
in prescribing rates between village clinics and higher-level healthcare facilities may 
exacerbate inequalities in health through disproportionately exposing poorer individuals 
to unnecessary antibiotic use. 
 
• Doctors have gaps between their knowledge and attitudes concerning antibiotics, and 
their actual prescribing practices. This is despite a majority having recently attended 
training on rational antibiotic use. There is a need to investigate which additional drivers 
are causing doctors to overuse and misuse antibiotics despite knowing that they are not 
needed. 
 
• Rural residents and backyard pig farmers have low levels of knowledge about what 
antibiotics are and when they should be used. Their knowledge and attitudes may 
contribute to overuse and misuse of antibiotics through promoting self-treatment and 
through creating expectations to receive antibiotics from healthcare professionals in 
situations for which they are not clinically needed. 
 
• Backyard pig farmers have differences in their knowledge, attitudes and practices towards 
antibiotic use in humans compared with other rural residents, and these appear to be 
inter-related with their knowledge, attitudes and practices towards antibiotic use in pigs. 
 
• In resource-limited settings, high quality, cross-sectoral assessments of antibiotic use at a 
small number of study sites can provide valuable insights into how responsibly antibiotics 
are being used.  
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8 RECOMMENDATIONS 
8.1 PRACTICE AND POLICY 
It is clear that actions must be taken globally to improve how we use antibiotics [1,4,21,212]. 
These actions are needed to ensure that people and animals have access to effective therapy 
today, and so that we can preserve the effectiveness of our limited arsenal of antibiotics for 
the patients of tomorrow [42,50]. These actions include individual doctors and healthcare 
facilities, healthcare systems and politicians, and the general public: everyone needs to be 
involved, and everyone has a role to play [4,47]. 
 
A wide range of effective interventions for improving antibiotic use have previously been 
described [97,213–215], but these should be context-adapted to maximise their impact. 
Change on a large scale is possible in China, as evidenced by the rapid and sustained 
reductions in antibiotic use seen across many urban hospitals that have coincided with 
national campaigns [110]. The results in this thesis provide several suggestions for how to 
proceed to improve antibiotic use in rural Shandong province and in similar settings for 
humans and on backyard pig farms. These include: 
 
Investing in education and public awareness 
Healthcare professionals: Educating prescribers in human and animal healthcare about the 
rational use of antibiotics is a key goal of the Chinese National Action Plan on Antimicrobial 
Resistance [148]. Several studies, including in China, have demonstrated that educational 
interventions can be low cost, scalable and effective at improving antibiotic prescribing 
[97,216,217]. Within human healthcare, our results suggest that education may be needed to 
help doctors understand which clinical conditions require antibiotics, but perhaps more 
importantly, it must provide them with alternatives to prescribing antibiotics for when they 
are not needed. This could include training on medications that provide symptomatic relief 
for viral illnesses, such as anti-inflammatories and analgesics, and on communication skills 
to help doctors address patients’ expectations without resorting to prescribing antibiotics. In 
China in particular, there may also be a role for promoting the use of traditional Chinese 
medicines. 
 
Rural residents: Remarkably, despite no previous active efforts to educate the public in the 
region, half of the rural residents who knew what antibiotics are thought that their individual 
practices were important for controlling resistance. This suggests that public awareness 
campaigns will benefit from providing rural residents with a basic understanding of what 
antibiotics are, and from empowering them to know what actions they can take to keep 
antibiotics effective. These include visiting healthcare providers instead of using leftover 
antibiotics or purchasing antibiotics without a prescription. Furthermore, residents need to 
be more aware of which conditions do not need antibiotics, and of how their demands may 
result in prescribers and pharmacies providing them with antibiotics when they are not 
needed. 
 
Backyard pig farmers: Farmers should be encouraged to seek advice from veterinarians and 
para-veterinarians when their pigs are ill, instead of self-treating with antibiotics. 
Promisingly, farmers had very high trust levels in veterinarians, and most did not think it was 
expensive to consult with them. Farmers should also be discouraged from adding antibiotics 
to feed as growth promoters. 
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Providing feedback to doctors 
Electronic prescribing records are increasingly common in primary care facilities in rural 
China. These could be harnessed to provide timely individualised feedback to doctors on both 
the quality and quantity of their antibiotic prescribing, in particular for conditions where they 
are not needed [195]. Furthermore, given the variation in antibiotic prescribing observed 
between individuals, doctors could be encouraged to discuss their prescribing patterns with 
one another, to help better understand facilitators and barriers to responsible antibiotic use. 
 
Restricting over-the counter access to antibiotics 
The results of our studies suggest that antibiotics remain easily accessible over-the-counter, 
both for humans and animals. The Chinese National Action Plan includes a goal that 
antibiotics for human use should be prescription-only by 2020 [148], but recent studies 
suggest that this target is unlikely to be met [182,183]. Stronger efforts to enforce this 
regulation are needed. 
 
Reducing fixed pack dispensing of antibiotics 
Antibiotics are commonly dispensed in fixed pack sizes in China. Instead, providing only the 
number of antibiotics actually prescribed by a doctor could help reduce the number of 
leftover antibiotics, and in turn reduce the likelihood of patients self-treating [218]. 
 
Restricting the use of antibiotics as growth promoters 
It is legal to use antibiotics as growth promoters in agriculture in China, although there are 
now restrictions on the types of antimicrobial agents that can be used [134]. International 
recommendations suggest that this use of antibiotics should be further curtailed [4,189]. 
 
8.2 FUTURE RESEARCH 
Our study methodology and surveys provide a model for how similar investigations could be 
conducted to assess how antibiotics are being used in other resource-limited settings. Our 
findings also suggest several questions that future research could address: 
 
• What are the underlying reasons behind the gaps between doctors’ reported 
knowledge and attitudes towards antibiotic use, and their actual prescribing 
practices? Can addressing these reasons improve antibiotic prescribing? 
 
• Why is there so much variation in practices between individual village doctors? How 
much of this variation can be explained in terms of patient-related factors? 
 
• Why do some village doctors have very low rates of parenteral- and multiple-
antibiotic use? 
 
• Why are some patients that are diagnosed with pneumonia not being prescribed 
antibiotics? 
 
• Is there a gradient across socioeconomic groups in terms of access to information 
about appropriate antibiotic use? 
 
• Do interventions that target farmers’ knowledge, attitudes and practices towards 
antibiotic use in animals also affect their knowledge, attitudes and practices towards 
antibiotic use in humans?  
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Lyrics to Universum, written by Madeleine Wittmark, Ensemble Yria 
 
For as long as I can remember, there’s always been a certain thrill in thinking about what we 
know, what we don’t know, and how we might be able to get answers to the questions that 
we don’t yet have the solutions to. I like to think of research as being a journey into outer 
space, to reach the frontiers of our current knowledge – and then exploring ways to go 
further. In school and at undergraduate level it was mostly about the first part, travelling 
increasingly deeper within known space. At a postgraduate level it became about pushing 
past the boundary that lies between the known and the unknown. As a doctoral student I 
have had the unique opportunity to take this trip full time, for which I am extremely grateful. 
 
I first became interested in infections and microbiology in school. In the beginning it was 
viruses: I found something indescribably elegant in how simple they were, yet how successful 
they managed to be. One of my first jobs was in the science department at a local bookshop. 
This helped provide the resources to fuel my passion further, but unfortunately the employee 
discount on buying books proved to be such a strong incentive that I’m fairly sure I never 
actually made any money from all the hours I worked there. During my undergraduate years 
at medical school I specialized in infections and immunity, and then during my master’s 
thesis I first had the chance to work with antibiotic resistance. I was hooked. This was a 
rapidly-evolving area of science that united several of my growing interests: global health, 
human behaviour, education, political actions, systems approaches, ethical dimensions, 
clinical relevance, and, of course, bugs. 
 
I was fortunate over the following decade to be invited to go on journeys into the unknown 
together with several researchers spread across the globe – the most significant journey, of 
course, being the one described in these pages. These journeys are now slowly drawing to an 
end and I look forward to returning to clinical practice. I have learnt a lot from the time I 
have been a researcher, both about the world and myself. I am eagerly anticipating the 
journeys that are yet to come, whichever parts of our universe they end up involving.
Om vi åker längre än längst, 
högre än högst, 
var hamnar vi då? 
 
Den nattsvarta himlen är sån, 
den tar aldrig slut. 
Hur kan det vara så? 
 
Universum, 
ger mig svindel 
Universum, 
Oändligheten. 
 
Hur många stjärnor finns det? 
Vad är en evighet? 
Finns det oändligt med platser 
vi aldrig får se... 
 
Och hur kan man veta det? 
If we journey further than the furthest, 
higher than the highest, 
where do we end up? 
 
The night black sky is like that, 
it never ends. 
How can that be so? 
 
The universe, 
it makes me dizzy, 
The universe, 
Infinity. 
 
How many stars are there? 
What is an eternity? 
Is there endless space 
we never get to see… 
 
And how can we know that? 
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APPENDIX I: QUESTIONNAIRE FOR RURAL RESIDENTS AND BACKYARD PIG FARMERS 
 
 
 
Research questionnaire of interaction, transmission and intervention of 
antibiotics resistance among animals and humans in the rural area of 
Shandong Province 
 
 
Village: ____________          Name: ____________  
 
                         No.___________            Date of investigation: _____Year____Month____Day 
                                   
                        
                                                                                                                                        Data collector_________  
                                                                                                                                        Data checker________ 
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Section one: Basic information and life habits of individuals 
 
No. Question Answer Type Comments 
1.1 Gender of respondent ①Male ②Female  
1.2 Age of respondent _______years old  
1.3 How many people live with you 
in the past 6 months.  
  
1.4 What are the ages of other people 
in the household? 
 ①_________②________③_________④__________⑤___________  
1.5 What are the relations to you of 
other people in the household? 
 ①_________②________③_________④__________⑤___________  
1.6 Does anyone in your household 
work outside the village? 
① Yes, I do ② Yes, somebody else in my household does ③ No, nobody does 
 
Tick all that 
apply 
1.7 Education level of respondent ①illiterate/half illiteracy ②primary school ③middle school ④high school/technical school/technical secondary school ⑤college ⑥university or above 
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1.8 Occupation of respondent ①farmer without a household farm ② small scale household farm ③ big scale commercial farm ④	worker (not on a farm) ⑤ administrator of village ⑥ teacher ⑦village doctor ⑧ student ⑨ military service ⑩ businessman 
(11) otherspecify  
 
1.8.1 Do you have any contact with 
animals on most days? 
① Yes, I do ②	No  
1.8.2 How often do you visit farms or 
households with animals, outside 
of your village? 
① Every day ② At least once a week ③ At least once a month ④ At least once every six months ⑤ Less often than once every six months  
 
1.8.3 Does anyone in your household 
have any contact with animals on 
most days? 
① Yes, I do ② Yes, somebody else in my household does ③ No Tick all that apply 
1.9 Are you covered by any medical 
insurance?  
① New rural cooperative medical insurance ② Medical insurance for urban residents ③ Commercial medical insurance ④ At my own expense (no medical insurance) ⑤ Other (specify)  
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1.10 Total (gross) yearly income of 
household during the last year 
 
_______________RMB 
Including job, 
income from 
farm 
1.11 Do you eat meat? ① Yes ② No (skip to 1.10)  
1.11.1 Do you eat mostly market-
bought meat or meat from home-
raised animals? 
① Market-bought ② Home raised ③ About half and half  
1.11.2 How many days do you eat pork 
in a week? 
______ days 
 
Write a 
number, not a 
range 
1.11.3 How many days do you eat 
chicken in a week? 
______ days 
 
Write a 
number, not a 
range 
1.12 How many days do you eat raw 
vegetables in a week? (e.g. lettuce, 
raw cucumber etc.)  
______ days 
 
Write a 
number, not a 
range 
1.13 Where do you mostly get your 
daily-use water from? 
 
1.13.1 
Source of 
water for 
drinking 
1.13.2 Source of water 
for washing and 
rinsing 
1.13.3 Source of 
water for rinsing 
vegetables 
1.13.4 Source of 
water for 
washing clothes 
1.13.5 Source of 
drinking water 
for pigs 
1.13.6 Source of 
water for cleaning 
pigs (e.g. for 
cleaning the pigsty) 
      ① Home tap water ② Private well ③ Shared well ④ River water ⑤ Other (specify) ⑥ Not relevant/I have no pigs 
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1.14 How often do you drink unboiled 
water taken directly from a tap or 
well? 
 
①Every day ②At least once a week ③At least once a month ④Less than once a month ⑤ I never do this 
Select one 
1.15 Do you usually wash your hands: 
 
1.15.1 Before meals 1.15.2 After going to the 
toilet 
1.15.3 Before working with 
the pigs 
1.15.4 After working with 
the pigs 
    ① Always ②Frequent ③Often ④Sometimes ⑤Never ⑥Not relevant 
1.16 How do you usually wash your 
hands: 
(for each option where the 
answer was Always, Often, or 
Sometimes to 1.13) 
 
1.16.1 Before meals 1.16.2 After going to the 
toilet 
1.16.3 Before working with 
the pigs 
1.16.4 After working with 
the pigs 
    ① Wash with soap ② Wash with water only ③ Other (specify) ④Do not wash hands ⑤Not relevant/I 
have no pigs 
1.17 What kind of toilet do you mostly 
use? 
① Self-owned toilette in the yard or outside of the house ② Toilet inside the house ③ Outdoor shared toilet  
1.17.1 Is the toilet with water-flush or 
aqua privies? 
① Water-flush ② Traditional dry type  
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1.18 What animals, and roughly how 
many of each, do you have in 
your household and household 
farm now? 
chicken______ 
duck______ 
dog______ 
cat______ 
goat______ 
sheep______ 
cow______ 
donkey______ 
mink ______ 
other______ 
1.19 Do you use human faecal or 
animal manure as fertilizer? 
① Human faecal ② Animal faecal ③ Human faecal and animal faecal ④	No 
Tick all that 
apply 
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Section two: Household health status  
 
No. Question Answer type  Comments 
   01 Interviewee 02 Other members of 
household 
 
2.1 Have you used any medicines 
(including traditional Chinese 
medicines) to prevent infections in the 
past six months? 
①Traditional Chinese products ②Western medicines  ③No   Tick all that apply 
2.2 Have you or your families taken any 
medicines during the last month 
(orally) due to newly emerged diseases, 
not including chronic diseases 
①Yes, in the past week ②Yes, in the past month ③No (skip to 2.3)   Select one 
2.2.1 For what kind of disease did you take 
the medicine(s)? 
Open (can include multiple)    
2.2.2 Which medicine(s)? Write the name of medicine (can be 
multiple) 
   
2.2.3 Where did you obtain the medicine(s)?  ①village clinic ②town clinic ③county hospital ④Pharmacy in village ⑤Pharmacy in town/city ⑥Other (specify)  
  Tick all that 
apply 
2.3 Have you or your family had any IV 
infusions or injections in the past six 
months? 
①yes ②no (skip to 2.4)    
2.3.1 When was the most recent IV infusion 
or injection? 
①In the past week ②In the past month ③Over a month ago   Select one 
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2.3.2 Reason for the most recent IV infusion 
or injection 
Open  
 
  
2.3.3 Place ①village clinic ②town clinic ③county hospital ④Other (specify)  
  Select one 
2.3.4 Medicine(s) in the infusion/injection Open     
Most recent stay in hospital  
2.4 Have you or someone in your family 
stayed overnight in hospital in the past 
year? 
①yes ②no (skip to 2.5) 
 
   
2.4.1 When was your most recent hospital 
stay? 
①In the past week ②In the past month ③Over a month ago   Select one 
2.4.2 Reason for most recent stay in the 
hospital 
 Open     
2.4.3 Type of hospital  ①Village clinic ②Town clinic ③County hospital ④Above county level hospital ⑤Other (specify) 
  Select one 
2.4.4 Did you have an operation?  ①yes ②no    
2.4.5 How many days did you stay in the 
hospital? 
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Section three: Knowledge, attitude and practices towards use and resistance of antibiotics 
 
No. Question Answer type Comments 
 Knowledge 
3.1 Do you know what antibiotics are? ①Yes (please describe) ②No 
 
 
3.2.1 Please point out which of the following drugs are antibiotics (maximum of three)? 
 3.1.1 Amoxicillin  3.1.2 Paracetamol  3.1.3 Simvastatin  3.1.4 Qingkailing 
Capsule 
 
 
 3.1.5 Erythromycin  3.1.6 Cephradine  3.1.7 Aspirin  3.1.8 Cephalexin  
 3.1.9 Dioctahedral smectite  3.1.10 Compound liquorice tablets  3.1.11 Ibuprofen  3.1.12 Compound 
acetaminophen 
 
3.2.1 Please point out which of the following drugs are anti-inflammatory drugs (maximum of three)? 
 3.2.1Amoxicillin  3.2.2 Paracetamol  3.2.3 Simvastatin  3.2.4 Qingkailing 
Capsule 
 
 3.2.5 Erythromycin  3.2.6 Cephradine  3.2.7 Aspirin  3.2.8 Cephalexin  
 3.2.9 Dioctahedral smectite  3.2.10 Compound liquorice tablets  3.2.11 Ibuprofen  3.2.12 Compound 
acetaminophen 
 
After 3.2.1, say to all participants: “As a reminder, antibiotics are medications that are used to treat bacteria that cause some infections/transmitted 
diseases” 
3.3 Antibiotics should always be used whenever an adult has a 
fever 
①yes ②no ③I don’t know  
3.4 Antibiotics should always be used whenever a child has a fever ①yes ②no ③I don’t know  
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3.5 Can taking antibiotics in advance protect people from the 
common cold? 
①yes ②no ③I don’t know  
3.6 Can antibiotics prevent a common cold developing into more 
severe disease such as pneumonia? 
①yes ②no ③I don’t know  
3.7 Do you feel that the same antibiotic has less effect than before if 
you use it again? 
①yes ②no ③I don’t know  
3.8 Bacteria can become resistant to antibiotics ①yes ②no ③I don’t know  
3.9 Humans can become resistant to antibiotics ①yes ②no ③I don’t know  
3.10 Animals can become resistant to antibiotics ①yes ②no ③I don’t know  
3.11 Can bacteria which have resistance towards antibiotics infect 
you or your family 
①yes ②no ③I don’t know  
3.12 Where do you mainly hear about antibiotics resistance? ①TV ②Radio ③Internet ④Conversation with other people ⑤Other (specify) 
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 Attitudes   
3.13 Please let us know your attitude towards antibiotics if you or your families suffer from the following diseases:   
3.13.1 common cold ①have to use antibiotics every time ②have to use antibiotics most times ③have to use antibiotics sometimes ④there is no need to use antibiotics ⑤I don’t know 
 
3.13.2 Sore throat ①have to use antibiotics every time ②have to use antibiotics most times ③have to use antibiotics sometimes ④there is no need to use antibiotics ⑤I don’t know 
 
3.13.3 hypertension  ①have to use antibiotics every time ②have to use antibiotics most times ③have to use antibiotics sometimes ④there is no need to use antibiotics ⑤I don’t know 
 
3.13.4 pneumonia ①have to use antibiotics every time ②have to use antibiotics most times ③have to use antibiotics sometimes ④there is no need to use antibiotics ⑤I don’t know 
 
3.13.5 Diabetes mellitus ①have to use antibiotics every time ②have to use antibiotics most times ③have to use antibiotics sometimes ④there is no need to use antibiotics ⑤I don’t know 
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3.13.6 asthma ①have to use antibiotics every time ②have to use antibiotics most times ③have to use antibiotics sometimes ④there is no need to use antibiotics ⑤I don’t know 
 
3.13.7 diarrhea ①have to use antibiotics every time ②have to use antibiotics most times ③have to use antibiotics sometimes ④there is no need to use antibiotics ⑤I don’t know 
 
3.13.8 urinary tract infection ①have to use antibiotics every time ②have to use antibiotics most times ③have to use antibiotics sometimes ④there is no need to use antibiotics ⑤I don’t know 
 
3.14 Would you trust the village doctor if they give you medicines 
when you or your family are suffering from above diseases 
such as common cold, diarrhea or pneumonia? 
①trust ②do not trust ③I don’t know  
3.15 Would you trust the county/town doctors if they give you 
medicines when you or your family are suffering from above 
diseases such as common cold, diarrhea or pneumonia?  
①trust ②do not trust ③I don’t know  
3.16 Would you trust the staff working at the pharmacy if they give 
you medicines when you or your family are suffering from 
above diseases such as common cold, diarrhea or pneumonia? 
①trust ②do not trust ③I don’t know  
3.17 I expect the doctor to prescribe me antibiotics when I feel it is 
needed. 
①agree ②disagree ③I don’t know  
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3.18 Antibiotic can only be purchased with prescriptions from 
doctors.  
①agree ②disagree ③I don’t know  
3.19 When taking antibiotics, even if you start to feel better, you 
should insist on taking the full course based on doctor’s advice. 
①agree ②disagree ③I don’t know  
3.20 Do you worry about antibiotic resistance? ①Yes ②No ③I don’t understand  
3.21 I believe that my own practices towards controlling antibiotics 
resistance is very important 
①agree ②disagree ③I don’t know  
 Reported practices   
3.22 Have you ever purchased antibiotics at pharmacy during the 
past year? 
①yes ②no (skip to 3.24)   ③I don’t know (skip to 3.24)    
3.22.1 In what type of pharmacy store did you purchase antibiotics? ①pharmacy in the village ②pharmacy in the town ③pharmacy in the city  
3.22.2 What antibiotics did you purchase? (list up to three they can 
remember) 
  
3.22.3 Did you have a prescription from a doctor when you purchased 
the antibiotics?  
① Yes, for all of them ② Yes, for most of them ③ Yes, for some of them ④ No, not for any 
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3.22.4 What are the main reasons why you would take antibiotics 
without visiting the doctor? 
①I won’t do that ②I have no time to see a doctor ③I don’t feel sick enough to see a doctor ④ I have leftover antibiotics from previous illness at home for 
similar symptoms ⑤ It’s more convenient to buy drugs from pharmacy stores ⑥ I don’t have money to visit a doctor ⑦other 
 
3.23 When do you normally stop taking antibiotics for an illness? ①when the symptoms start to disappear ②when I finish the amount of drugs that I was told to take   ③other  
3.24 In the past year, have you stored any antibiotics that are left 
over after an illness? 
①yes ②no ③I don’t know  
3.24.1 Have you already, or will you use these left-over antibiotics 
again, when you become ill? 
①yes ②no ③I don’t know  
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Section four: Prioritization during health seeking behavior 
 
No. Question Answer type Comments 
4.1 Which of the following are important to you 
when you suffer from an infection such as 
common cold or pneumonia?  
①getting better quickly ②knowing what caused the illness ③being able to work ④taking medicines ⑤cost of medicines ⑥others 
Tick all that 
apply 
4.1.1 Is there anything else that is important to you 
when you are suffering from an infection? 
Open  
4.1.2 Which of these is most important to you? Select the one that is most important from 4.1 or 4.1.1  
4.2 Which of the following are important to you 
when you visit the doctor and are suffering from 
an infection such as common cold or pneumonia? 
①physical examination ②obtaining information about the cause of the illness ③obtaining information about the duration of the illness ④if the doctor is going to prescribe me any antibiotics ⑤obtaining information about self-management ⑥other (please specify) 
Tick all that 
apply 
4.2.1 Is there anything else that is important to you 
when you visit the doctor and are suffering from 
an infection? 
Open  
4.2.2 Which of these is most important to you? Select the one that is most important from 4.2 or 4.2.1 Tick all that 
apply 
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Section five: Farm characteristics and pig health 
 
No. Question Answer type Comments 
5.1 Do you have pigs in your household now? ①Yes (skip to 5.1) ②No  
5.1.1 Have you had any pigs in your household in the 
past five years? 
①Yes (skip to section 6, don’t ask section 7) ②No (skip to section 8)  
5.2 How many years have you had pigs in your 
household for? 
____ years  
5.3 What type of pigs do you have? ① Sows, with piglets that I raise to slaughter ② Piglets that I buy and raise to slaughter ③ Sows, with piglets that I sell after weaning ④ a combination of 1) and 3) ⑤ Other (specify)  
 
5.4 How many pigs do you have now? Numbers of piglets_____ 
Weaners____ 
Slaughter pigs (weaned pigs)____ 
Sows (for breeding) ____ 
Boars (for breeding)____ 
 
5.5 Have you had any training about raising pigs? ① Yes, from a relative ② Yes, from another person in the village ③ Yes, at a professional course (Days_____) ④ Yes, other (specify) ⑤ No, learned by myself 
Tick all that apply 
5.6 What are the two most common diseases in 
your pigs? 
Open  
5.7 Have any of your pigs been unwell in the past 
month? 
① Yes, in the past week ② Yes, in the past month ③ No (skip to 5.8)  
5.7.1 What were the diseases in the past month?   
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5.7.2 What were their symptoms?   
5.7.3 How many days on average were they ill for? ____days ____days 
5.7.4 Did you give them any medication? ① Yes (specify) ② No ① Yes (specify) ② No 
5.8 Have you given any healthy pigs any 
medications in the past month (including 
traditional Chinese medicines)? 
① Yes (specify all medications given and 
why_______) ② No 
 
 
 
5.9 Which of the following are important to you 
when your pigs are suffering from an 
infection, such as diarrhea?  
① Knowing what caused the illness ② Knowing how severe the illness is ③ How long it takes them to recover ④ The cost of medicines ⑤ Preventing spread of the infection to other 
pigs ⑥ That I will lose all my possible profit from 
my pigs 
Tick all that apply 
5.9.1 Is there anything else that is important to you 
when your pigs are suffering from an 
infection? 
Open  
5.9.2 Which of these is most important to you? Select the one that is most important from 5.8 or 
5.8.1 
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Section six: Knowledge, attitudes and practices towards pig antibiotic use and antibiotic resistance 
 
No. Question Answer type Comments 
 Start with introduction to antibiotics again: As I said earlier, antibiotics are medications that are used to 
treat bacteria that cause some infections/transmitted diseases 
 
 Knowledge   
6.1 Can you mention two pig diseases that are normally 
treated with antibiotics? 
Open  
6.2 Should antibiotics be used whenever a pig stops eating 
its feed 
① Yes ② No ③ I don’t know  
 Attitudes   
6.3 I know when my pigs need medications ①agree ②disagree ③I don’t know  
6.4 It is good to keep left over antibiotics at the farm to use 
them again in the future 
①agree ②disagree ③I don’t know  
6.5 I would trust the vet if they decided to give a 
medication to a pig with an infection 
①agree ②disagree ③I don’t know  
6.6 It is expensive to get advice on pig health and 
management from a vet 
①agree ②disagree ③I don’t know  
6.7 It is expensive to buy antibiotics for my pigs ①agree ②disagree ③I don’t know  
 Practices   
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6.8 Do you usually seek advice from other people if your 
pigs are sick? 
① Yes, from vet ② Yes, from animal pharmacy ③ Yes, from other farmers ④ Other (specify) ⑤ No 
Tick all that 
apply 
6.9 Do you have these behaviors when you use antibiotics? ① Always or often in feed, to keep the pigs healthy and prevent 
disease ② For all pigs in a pen, when some of the pigs in the pen are 
sick ③ Only in pigs showing disease 
Select one 
6.9.1 Are there any other reasons why you use antibiotics? ①yes  ②no  
6.10 Where do you most commonly buy antibiotics for 
your pigs? 
① From a vet ② From an animal pharmacy ③ From a human pharmacy ④ From the market ⑤ From another household farm ⑥ Other (specify)  
Tick all that 
apply 
6.11 What are the three antibiotics that you most 
commonly use for your pigs? 
Open (list up to three)  
6.12 Do you use traditional Chinese medicines for your 
pigs? 
① Yes ② No (skip to 6.13)  
6.12.1 What are the main reasons you use traditional Chinese 
medicines for your pigs? 
Open  
6.13 In the past year, have you purchased antibiotics for 
your pigs without first speaking with a vet/? 
① Yes ② No  
6.14 What are the main reasons why you would give 
antibiotics to your pigs without first speaking with a 
vet/animal health advisor? 
Open  
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Section seven: Biosecurity on household farms 
   
No. Question Answer type Comments 
7.1 What feed do you use for your pigs? ① Own feed ② Feed from another farmer ③ Commercial feed ④ Other (specify) 
Tick all that 
apply 
7.2 Do you always clean the pens more thoroughly 
when they are empty? 
① Yes ② No  
7.3 What do you clean the pens with when you clean 
them more thoroughly? 
① With water first, then disinfectant ② With disinfectant only ③ With soap and water ④ With only water ⑤ Other (specify) 
Select one 
7.4 How often do you buy pigs? ① Many times a year ② Once a year ③ Once every two years ④ Less often than once every two years 
Select one 
7.5 Where do you normally buy pigs from? ① My village ② Another village ③ A mixture of villages ④ Other (specify) 
Select one 
7.5.1 What sort of place do you normally buy pigs 
from? 
① Village farm ② Commercial farm ③ Market ④ Other (specify) 
Y/N for each 
option 
7.6 Do you keep newly bought pigs separate from 
other pigs for some time? 
① Yes (how long for _______) ② No   
7.7 On average, how often do you sell animals?   
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Section eight: Medicines currently in household 
 
No. Question Answer type Comments 
8.1 Which medicines do you 
have in your home at the 
moment for you or your 
family?  
Please write down ALL medicines (names only) For each medicine, ask if they think it is an 
antibiotic and record Yes, No or Don’t 
know 
 
8.2 Which medicines do you 
have in your home at the 
moment for your pigs? 
Please write down ALL medicines (names only). For each medicine, ask if they think it is an 
antibiotic and record Yes, No or Don’t 
know 
 
 
